,bcr_patient_uuid,pharmaceutical_therapy_drug_name,pharmaceutical_therapy_type,vital_status,tumor_status,treatment_outcome_first_course,treatment_best_response,death_days_to,gender,age_at_initial_pathologic_diagnosis,icd_10,tumor_tissue_site,tumor_type
0,fc222f23-b3b2-4ac0-bc61-e8e8fa5cc160,Temodar,Chemotherapy,Dead,WITH TUMOR,,,234,MALE,67,C71.9,Central nervous system,Low-grade gliomas
1,230f5fa7-aa36-41ea-b40b-08f520767bd5,Avastin,Chemotherapy,Dead,WITH TUMOR,,,1335,FEMALE,44,C71.9,Central nervous system,Low-grade gliomas
2,952dfd5d-e65a-4307-b6a9-2ed2b0d2d9ce,Temodar,Chemotherapy,Alive,WITH TUMOR,,,,MALE,37,C71.9,Central nervous system,Low-grade gliomas
3,c6cf2b8e-40ed-4c9f-8419-d868bd5afe11,Temodar,Chemotherapy,Alive,TUMOR FREE,,,,FEMALE,47,C71.9,Central nervous system,Low-grade gliomas
4,e8d3d888-e5fc-4469-ad0b-2c1df6e04790,Temodar,Chemotherapy,Alive,TUMOR FREE,,,,MALE,39,C71.9,Central nervous system,Low-grade gliomas
5,f86fa219-34e9-4812-8edf-2b66d7219779,Bevacizumab,Chemotherapy,Dead,WITH TUMOR,,,639,MALE,43,C71.9,Central nervous system,Low-grade gliomas
6,f86fa219-34e9-4812-8edf-2b66d7219779,Temodar,Chemotherapy,Dead,WITH TUMOR,,,639,MALE,43,C71.9,Central nervous system,Low-grade gliomas
7,b6c2c9bd-625b-4a98-830c-49c344f6cb5f,Temodar,Chemotherapy,Alive,WITH TUMOR,,,,FEMALE,53,C71.9,Central nervous system,Low-grade gliomas
8,bdfade49-9059-4665-beea-c55117ba6564,Temodar,Chemotherapy,Dead,WITH TUMOR,,,194,FEMALE,54,C71.9,Central nervous system,Low-grade gliomas
9,9ee6e821-3af2-42d7-9d14-f0ca455f338c,Temodar,Chemotherapy,Dead,WITH TUMOR,,,538,MALE,58,C71.9,Central nervous system,Low-grade gliomas
10,9ee6e821-3af2-42d7-9d14-f0ca455f338c,Avastin,Chemotherapy,Dead,WITH TUMOR,,,538,MALE,58,C71.9,Central nervous system,Low-grade gliomas
11,3f70c3e3-0131-466f-92aa-0a63ab3d4258,Temodar,Chemotherapy,Alive,WITH TUMOR,,,,MALE,48,C71.9,Central nervous system,Low-grade gliomas
12,42fe260f-520b-4fac-8c09-d2b31aed59fb,Temodar,Chemotherapy,Alive,,,,,MALE,31,C71.9,Central nervous system,Low-grade gliomas
13,c16d9f69-26f9-4ec7-b2d5-ff9f7dacfe0f,Temodar,Chemotherapy,Alive,WITH TUMOR,,,,FEMALE,51,C71.9,Central nervous system,Low-grade gliomas
14,8cba230b-46db-4d35-8123-3879eba32402,Temodar,Chemotherapy,Alive,WITH TUMOR,,,,MALE,22,C71.9,Central nervous system,Low-grade gliomas
15,a5d3f3fb-6541-419d-b47e-720d438f1bff,Temodar,Chemotherapy,Alive,WITH TUMOR,,,,FEMALE,57,C71.9,Central nervous system,Low-grade gliomas
16,dc5bdd21-b23f-400e-bbe2-4c98a517fc9e,Temodar,Chemotherapy,Alive,WITH TUMOR,,,,FEMALE,26,C71.9,Central nervous system,Low-grade gliomas
17,60b30a95-3e4c-413a-9de6-16a5bca163c4,Temodar,Chemotherapy,Alive,WITH TUMOR,,,,MALE,43,C71.9,Central nervous system,Low-grade gliomas
18,60b30a95-3e4c-413a-9de6-16a5bca163c4,Vinblastine,Chemotherapy,Alive,WITH TUMOR,,,,MALE,43,C71.9,Central nervous system,Low-grade gliomas
19,60b30a95-3e4c-413a-9de6-16a5bca163c4,Avastin,Chemotherapy,Alive,WITH TUMOR,,,,MALE,43,C71.9,Central nervous system,Low-grade gliomas
20,b7cd3b44-ef6a-4207-a44f-14f5b3b56ed4,BCNU,Chemotherapy,Alive,TUMOR FREE,,,,FEMALE,38,C71.0,Central nervous system,Low-grade gliomas
21,ae2db022-eb4f-4b65-89b6-9fd4439ddeef,Temodar,Chemotherapy,Alive,TUMOR FREE,,,,MALE,33,C71.0,Central nervous system,Low-grade gliomas
22,ae2db022-eb4f-4b65-89b6-9fd4439ddeef,Temodar,Chemotherapy,Alive,TUMOR FREE,,,,MALE,33,C71.0,Central nervous system,Low-grade gliomas
23,0b54cda4-7568-481e-b0c6-2c5c6de0026c,Temodar,Chemotherapy,Alive,TUMOR FREE,,,,FEMALE,37,C71.0,Central nervous system,Low-grade gliomas
24,0b54cda4-7568-481e-b0c6-2c5c6de0026c,Temodar,Chemotherapy,Alive,TUMOR FREE,,,,FEMALE,37,C71.0,Central nervous system,Low-grade gliomas
25,bbfb5399-8d43-4b75-bf90-23ec142697d7,Temodar,Chemotherapy,Alive,TUMOR FREE,,,,MALE,36,C71.0,Central nervous system,Low-grade gliomas
26,bbfb5399-8d43-4b75-bf90-23ec142697d7,Temodar,Chemotherapy,Alive,TUMOR FREE,,,,MALE,36,C71.0,Central nervous system,Low-grade gliomas
27,9d0c1552-00a7-4f0a-a04a-a82e721ee4e3,Temodar,Chemotherapy,Alive,TUMOR FREE,,,,MALE,32,C71.0,Central nervous system,Low-grade gliomas
28,9d0c1552-00a7-4f0a-a04a-a82e721ee4e3,Temodar,Chemotherapy,Alive,TUMOR FREE,,,,MALE,32,C71.0,Central nervous system,Low-grade gliomas
29,9d0c1552-00a7-4f0a-a04a-a82e721ee4e3,Gleevec,Targeted Molecular therapy,Alive,TUMOR FREE,,,,MALE,32,C71.0,Central nervous system,Low-grade gliomas
30,9d0c1552-00a7-4f0a-a04a-a82e721ee4e3,Gleevec,Targeted Molecular therapy,Alive,TUMOR FREE,,,,MALE,32,C71.0,Central nervous system,Low-grade gliomas
31,d05079f2-9883-46e6-ad06-9e561f08d819,Temodar,Chemotherapy,Alive,WITH TUMOR,,,,MALE,34,C71.0,Central nervous system,Low-grade gliomas
32,d05079f2-9883-46e6-ad06-9e561f08d819,Temodar,Chemotherapy,Alive,WITH TUMOR,,,,MALE,34,C71.0,Central nervous system,Low-grade gliomas
33,d05079f2-9883-46e6-ad06-9e561f08d819,Temozolamide,Chemotherapy,Alive,WITH TUMOR,,,,MALE,34,C71.0,Central nervous system,Low-grade gliomas
34,15a6ad18-a81c-4f5b-80ae-ef56ccf722f9,Temodar,Chemotherapy,Alive,WITH TUMOR,,,,MALE,61,C71.0,Central nervous system,Low-grade gliomas
35,15a6ad18-a81c-4f5b-80ae-ef56ccf722f9,Temodar,Chemotherapy,Alive,WITH TUMOR,,,,MALE,61,C71.0,Central nervous system,Low-grade gliomas
36,FB6437F9-ADE8-4C33-A0D0-CEACB2BF784D,Temodar,Chemotherapy,Alive,TUMOR FREE,Stable Disease,Stable Disease,,MALE,38,C71.4,Central nervous system,Low-grade gliomas
37,1BFF1E07-4923-43D5-B2D3-CB46B6568EED,Temodar,Chemotherapy,Alive,TUMOR FREE,Complete Remission/Response,Complete Response,,MALE,32,C71.2,Central nervous system,Low-grade gliomas
38,40587B69-0F62-4A2A-88CB-1BD711377F19,Temodar,Chemotherapy,Alive,WITH TUMOR,Stable Disease,Stable Disease,,FEMALE,41,C71.1,Central nervous system,Low-grade gliomas
39,7704E4A8-C7AA-4288-B1ED-68C23ABBE924,Temodar,Chemotherapy,Alive,WITH TUMOR,Stable Disease,Stable Disease,,MALE,34,C71.1,Central nervous system,Low-grade gliomas
40,0536F465-1650-4411-823C-C660BC7F3ADC,Temodar,Chemotherapy,Alive,WITH TUMOR,Stable Disease,Stable Disease,,MALE,59,C71.0,Central nervous system,Low-grade gliomas
41,12F02422-585D-4068-BBDE-BC279C6A89AB,Temodar,Chemotherapy,Alive,TUMOR FREE,Complete Remission/Response,Stable Disease,,MALE,40,C71.0,Central nervous system,Low-grade gliomas
42,887DEF39-E212-490D-8849-2BC932FCEFF0,Temodar,Chemotherapy,Alive,WITH TUMOR,Stable Disease,,,FEMALE,31,C71.0,Central nervous system,Low-grade gliomas
43,176D89D7-F8F1-4A72-B45A-31CBE1632A30,Temodar,Chemotherapy,Alive,WITH TUMOR,Stable Disease,Stable Disease,,MALE,54,C71.0,Central nervous system,Low-grade gliomas
44,DF22BC30-96E2-42DE-9A39-2954DB49841D,Temodar,Chemotherapy,Alive,WITH TUMOR,Stable Disease,Stable Disease,,FEMALE,65,C71.0,Central nervous system,Low-grade gliomas
45,9922DE10-9280-44C0-B86F-6D1CA7E55BF2,Temodar,Chemotherapy,Alive,TUMOR FREE,Stable Disease,Stable Disease,,FEMALE,56,C71.0,Central nervous system,Low-grade gliomas
46,5F853A88-811D-4EB4-914E-D90862C5D2A2,Temozolomide,Chemotherapy,Alive,TUMOR FREE,Complete Remission/Response,Complete Response,,FEMALE,55,C71.0,Central nervous system,Low-grade gliomas
47,BA62B5EB-E169-4B41-B949-E004D66E98A1,Temozolomide,Chemotherapy,Alive,TUMOR FREE,,,,FEMALE,36,C71.0,Central nervous system,Low-grade gliomas
48,0709DBCC-0828-4066-AA01-96F059E5FA97,CDR0000654697,Chemotherapy,Alive,TUMOR FREE,,,,MALE,47,C71.0,Central nervous system,Low-grade gliomas
49,2c03e8b9-8856-43a7-853d-5ec51a6e5330,Temozolomide,Chemotherapy,Dead,WITH TUMOR,,,607,FEMALE,38,C71.0,Central nervous system,Low-grade gliomas
50,2c03e8b9-8856-43a7-853d-5ec51a6e5330,AT 101,Targeted Molecular therapy,Dead,WITH TUMOR,,,607,FEMALE,38,C71.0,Central nervous system,Low-grade gliomas
51,2c03e8b9-8856-43a7-853d-5ec51a6e5330,Temozolomide,Chemotherapy,Dead,WITH TUMOR,,,607,FEMALE,38,C71.0,Central nervous system,Low-grade gliomas
52,2c03e8b9-8856-43a7-853d-5ec51a6e5330,BCNU (carmustine),Chemotherapy,Dead,WITH TUMOR,,,607,FEMALE,38,C71.0,Central nervous system,Low-grade gliomas
53,2cf49bac-dea1-45ff-9e1d-09f5a2ac5215,Temozolomide,Chemotherapy,Alive,,,,,MALE,32,C71.0,Central nervous system,Low-grade gliomas
54,2cf49bac-dea1-45ff-9e1d-09f5a2ac5215,Temozolomide,Chemotherapy,Alive,,,,,MALE,32,C71.0,Central nervous system,Low-grade gliomas
55,5b744051-7355-4e15-b035-0621e709a5d7,Temozolomide,Chemotherapy,Alive,TUMOR FREE,,,,MALE,29,C71.0,Central nervous system,Low-grade gliomas
56,5b744051-7355-4e15-b035-0621e709a5d7,Temozolomide,Chemotherapy,Alive,TUMOR FREE,,,,MALE,29,C71.0,Central nervous system,Low-grade gliomas
57,5b744051-7355-4e15-b035-0621e709a5d7,Temozolomide,Chemotherapy,Alive,TUMOR FREE,,,,MALE,29,C71.0,Central nervous system,Low-grade gliomas
58,dcd0856d-423a-40d7-8070-4c0988d61416,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,,,MALE,30,C71.0,Central nervous system,Low-grade gliomas
59,dcd0856d-423a-40d7-8070-4c0988d61416,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,,,MALE,30,C71.0,Central nervous system,Low-grade gliomas
60,dcd0856d-423a-40d7-8070-4c0988d61416,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,,,MALE,30,C71.0,Central nervous system,Low-grade gliomas
61,CB1E9916-C03F-405A-A797-15823DF09C8E,Temozolomide,Chemotherapy,Alive,WITH TUMOR,Stable Disease,Stable Disease,,MALE,52,C71.0,Central nervous system,Low-grade gliomas
62,F005FA99-7E4E-4308-B11C-83B25683B1FD,Temozolomide,Chemotherapy,Alive,TUMOR FREE,Stable Disease,Stable Disease,,FEMALE,43,C71.0,Central nervous system,Low-grade gliomas
63,DA40E6D3-A2A9-4517-AAA2-AEF6C3892EBF,Temodar,Chemotherapy,Alive,WITH TUMOR,Stable Disease,Partial Response,,FEMALE,49,C71.0,Central nervous system,Low-grade gliomas
64,B37ABDC8-B9E3-4F1A-B16D-2E59442DB335,Temodar,Chemotherapy,Alive,TUMOR FREE,Complete Remission/Response,Complete Response,,FEMALE,59,C71.0,Central nervous system,Low-grade gliomas
65,B2B57E93-2722-4546-9A0B-20155B86EDEF,Temodar,Chemotherapy,Alive,WITH TUMOR,Stable Disease,Stable Disease,,MALE,30,C71.0,Central nervous system,Low-grade gliomas
66,977118C8-B446-4696-AA6E-9F1A1055E241,Temodar,Chemotherapy,Alive,WITH TUMOR,Stable Disease,Stable Disease,,MALE,43,C71.0,Central nervous system,Low-grade gliomas
67,3B19B5D1-13AF-4669-A082-1BD546048185,Temodar,Chemotherapy,Alive,WITH TUMOR,,Stable Disease,,MALE,49,C71.0,Central nervous system,Low-grade gliomas
68,92a7c445-2217-400a-bdcd-df41502416b6,Bevacizumab,Targeted Molecular therapy,Alive,WITH TUMOR,,,,FEMALE,34,C71.9,Central nervous system,Low-grade gliomas
69,92a7c445-2217-400a-bdcd-df41502416b6,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,,,FEMALE,34,C71.9,Central nervous system,Low-grade gliomas
70,92a7c445-2217-400a-bdcd-df41502416b6,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,,,FEMALE,34,C71.9,Central nervous system,Low-grade gliomas
71,5af8ada5-86b5-4832-8a8e-e975ecca5515,Temozolomide,Chemotherapy,Alive,TUMOR FREE,,,,MALE,48,C71.9,Central nervous system,Low-grade gliomas
72,55c78413-d102-4113-930e-6d842862fe75,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,,,FEMALE,40,C71.9,Central nervous system,Low-grade gliomas
73,55c78413-d102-4113-930e-6d842862fe75,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,,,FEMALE,40,C71.9,Central nervous system,Low-grade gliomas
74,9ed5af0e-c87f-46ff-81e7-9d3041b4034e,Temozolomide,Chemotherapy,Dead,WITH TUMOR,,,205,FEMALE,61,C71.9,Central nervous system,Low-grade gliomas
75,2d42dd0e-be3a-46ae-a635-c6f9c52f9fa2,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,,,MALE,29,C71.9,Central nervous system,Low-grade gliomas
76,b95afb1a-a1df-4d85-ad34-191928e28a77,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,,,FEMALE,57,C71.9,Central nervous system,Low-grade gliomas
77,b95afb1a-a1df-4d85-ad34-191928e28a77,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,,,FEMALE,57,C71.9,Central nervous system,Low-grade gliomas
78,b95afb1a-a1df-4d85-ad34-191928e28a77,Bevacizumab,Targeted Molecular therapy,Alive,WITH TUMOR,,,,FEMALE,57,C71.9,Central nervous system,Low-grade gliomas
79,e326c1dd-2ef8-431b-a657-440aa3f35ff3,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,,,FEMALE,49,C71.9,Central nervous system,Low-grade gliomas
80,e326c1dd-2ef8-431b-a657-440aa3f35ff3,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,,,FEMALE,49,C71.9,Central nervous system,Low-grade gliomas
81,eb42625e-fbbb-4bee-bbe9-315b3ca2138a,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,,,FEMALE,34,C71.9,Central nervous system,Low-grade gliomas
82,eb42625e-fbbb-4bee-bbe9-315b3ca2138a,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,,,FEMALE,34,C71.9,Central nervous system,Low-grade gliomas
83,ddfd76dc-15d6-4efc-85ea-31674161ebf3,Temozolomide,Chemotherapy,Alive,TUMOR FREE,,,,FEMALE,37,C71.9,Central nervous system,Low-grade gliomas
84,ddfd76dc-15d6-4efc-85ea-31674161ebf3,Temozolomide,Chemotherapy,Alive,TUMOR FREE,,,,FEMALE,37,C71.9,Central nervous system,Low-grade gliomas
85,48607130-c09a-491d-882f-7d2591d13182,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,,,FEMALE,43,C71.9,Central nervous system,Low-grade gliomas
86,48607130-c09a-491d-882f-7d2591d13182,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,,,FEMALE,43,C71.9,Central nervous system,Low-grade gliomas
87,48607130-c09a-491d-882f-7d2591d13182,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,,,FEMALE,43,C71.9,Central nervous system,Low-grade gliomas
88,48607130-c09a-491d-882f-7d2591d13182,Bevacizumab,Targeted Molecular therapy,Alive,WITH TUMOR,,,,FEMALE,43,C71.9,Central nervous system,Low-grade gliomas
89,1cc53ade-73c0-492b-a7dc-328269fd0e66,Temozolomide,Chemotherapy,Alive,TUMOR FREE,,,,FEMALE,62,C71.9,Central nervous system,Low-grade gliomas
90,fcd9e1c4-bddb-4856-844c-03df48fba499,Hydroxyurea,Chemotherapy,Alive,TUMOR FREE,,,,FEMALE,35,C71.0,Central nervous system,Low-grade gliomas
91,fcd9e1c4-bddb-4856-844c-03df48fba499,PCV,Chemotherapy,Alive,TUMOR FREE,,,,FEMALE,35,C71.0,Central nervous system,Low-grade gliomas
92,1937318f-a1bb-4f48-b8ec-4aadd406e52a,Carmustine BCNU,Chemotherapy,Dead,,,,1585,MALE,66,C71.0,Central nervous system,Low-grade gliomas
93,42cc9620-98fb-4164-a3b2-28d084ca5a03,PCV,Chemotherapy,Dead,WITH TUMOR,,,682,MALE,53,C71.0,Central nervous system,Low-grade gliomas
94,42cc9620-98fb-4164-a3b2-28d084ca5a03,PCV,Chemotherapy,Dead,WITH TUMOR,,,682,MALE,53,C71.0,Central nervous system,Low-grade gliomas
95,42cc9620-98fb-4164-a3b2-28d084ca5a03,Hydroxyurea,Chemotherapy,Dead,WITH TUMOR,,,682,MALE,53,C71.0,Central nervous system,Low-grade gliomas
96,6355cade-7b3a-43a8-9f1f-8e7bc45755a8,Tamoxifen,Chemotherapy,Dead,WITH TUMOR,,,1491,MALE,31,C71.0,Central nervous system,Low-grade gliomas
97,6355cade-7b3a-43a8-9f1f-8e7bc45755a8,PCV,Chemotherapy,Dead,WITH TUMOR,,,1491,MALE,31,C71.0,Central nervous system,Low-grade gliomas
98,6355cade-7b3a-43a8-9f1f-8e7bc45755a8,PCV,Chemotherapy,Dead,WITH TUMOR,,,1491,MALE,31,C71.0,Central nervous system,Low-grade gliomas
99,152eaa99-05f5-4d30-bfb1-494a9a900e49,Isotretinoin,Targeted Molecular therapy,Dead,WITH TUMOR,,,2286,FEMALE,31,C71.0,Central nervous system,Low-grade gliomas
100,152eaa99-05f5-4d30-bfb1-494a9a900e49,Irinotecan,Chemotherapy,Dead,WITH TUMOR,,,2286,FEMALE,31,C71.0,Central nervous system,Low-grade gliomas
101,152eaa99-05f5-4d30-bfb1-494a9a900e49,9 Aminocamptothecin,Chemotherapy,Dead,WITH TUMOR,,,2286,FEMALE,31,C71.0,Central nervous system,Low-grade gliomas
102,152eaa99-05f5-4d30-bfb1-494a9a900e49,Tamoxifen,Hormone Therapy,Dead,WITH TUMOR,,,2286,FEMALE,31,C71.0,Central nervous system,Low-grade gliomas
103,152eaa99-05f5-4d30-bfb1-494a9a900e49,Capecitabine,Chemotherapy,Dead,WITH TUMOR,,,2286,FEMALE,31,C71.0,Central nervous system,Low-grade gliomas
104,152eaa99-05f5-4d30-bfb1-494a9a900e49,Bromo deoxyuridine,,Dead,WITH TUMOR,,,2286,FEMALE,31,C71.0,Central nervous system,Low-grade gliomas
105,152eaa99-05f5-4d30-bfb1-494a9a900e49,PCV,Chemotherapy,Dead,WITH TUMOR,,,2286,FEMALE,31,C71.0,Central nervous system,Low-grade gliomas
106,152eaa99-05f5-4d30-bfb1-494a9a900e49,Temozolomide,Chemotherapy,Dead,WITH TUMOR,,,2286,FEMALE,31,C71.0,Central nervous system,Low-grade gliomas
107,e695b780-17f4-4e71-9120-7c6bcafaa3a7,Temozolomide,Chemotherapy,Dead,WITH TUMOR,,,1401,MALE,45,C71.0,Central nervous system,Low-grade gliomas
108,97cb8701-7d63-4142-b404-006fbb3ecb0b,Sorafenib (Bay 43-9006),Chemotherapy,Dead,WITH TUMOR,,,2660,FEMALE,31,C71.0,Central nervous system,Low-grade gliomas
109,97cb8701-7d63-4142-b404-006fbb3ecb0b,Procarbazine,Chemotherapy,Dead,WITH TUMOR,,,2660,FEMALE,31,C71.0,Central nervous system,Low-grade gliomas
110,97cb8701-7d63-4142-b404-006fbb3ecb0b,Temozolomide,Chemotherapy,Dead,WITH TUMOR,,,2660,FEMALE,31,C71.0,Central nervous system,Low-grade gliomas
111,152f028e-ee29-40e0-8e75-5cafffacbd45,Temozolomide,Chemotherapy,Dead,WITH TUMOR,,,214,MALE,52,C71.0,Central nervous system,Low-grade gliomas
112,8daa29c0-f652-4130-a004-5183bbe30c63,BCNU (Carmustine),Chemotherapy,Dead,WITH TUMOR,,,354,FEMALE,60,C71.0,Central nervous system,Low-grade gliomas
113,8daa29c0-f652-4130-a004-5183bbe30c63,Hydroxyurea,Chemotherapy,Dead,WITH TUMOR,,,354,FEMALE,60,C71.0,Central nervous system,Low-grade gliomas
114,8daa29c0-f652-4130-a004-5183bbe30c63,Gliadel Wafer,Chemotherapy,Dead,WITH TUMOR,,,354,FEMALE,60,C71.0,Central nervous system,Low-grade gliomas
115,c0d47e0f-4918-4e06-9db6-201671b1259c,Carboplatin,Chemotherapy,Dead,WITH TUMOR,,,4068,FEMALE,24,C71.0,Central nervous system,Low-grade gliomas
116,c0d47e0f-4918-4e06-9db6-201671b1259c,Bevacizumab,Targeted Molecular therapy,Dead,WITH TUMOR,,,4068,FEMALE,24,C71.0,Central nervous system,Low-grade gliomas
117,c0d47e0f-4918-4e06-9db6-201671b1259c,Irinotecan,Chemotherapy,Dead,WITH TUMOR,,,4068,FEMALE,24,C71.0,Central nervous system,Low-grade gliomas
118,c0d47e0f-4918-4e06-9db6-201671b1259c,Temozolomide,Chemotherapy,Dead,WITH TUMOR,,,4068,FEMALE,24,C71.0,Central nervous system,Low-grade gliomas
119,c0d47e0f-4918-4e06-9db6-201671b1259c,Bevacizumab,Targeted Molecular therapy,Dead,WITH TUMOR,,,4068,FEMALE,24,C71.0,Central nervous system,Low-grade gliomas
120,c0d47e0f-4918-4e06-9db6-201671b1259c,Irinotecan,Chemotherapy,Dead,WITH TUMOR,,,4068,FEMALE,24,C71.0,Central nervous system,Low-grade gliomas
121,c0d47e0f-4918-4e06-9db6-201671b1259c,Temozolomide,Chemotherapy,Dead,WITH TUMOR,,,4068,FEMALE,24,C71.0,Central nervous system,Low-grade gliomas
122,c0d47e0f-4918-4e06-9db6-201671b1259c,Temozolomide,Chemotherapy,Dead,WITH TUMOR,,,4068,FEMALE,24,C71.0,Central nervous system,Low-grade gliomas
123,c0d47e0f-4918-4e06-9db6-201671b1259c,Bevacizumab,Targeted Molecular therapy,Dead,WITH TUMOR,,,4068,FEMALE,24,C71.0,Central nervous system,Low-grade gliomas
124,c0d47e0f-4918-4e06-9db6-201671b1259c,Bevacizumab,Targeted Molecular therapy,Dead,WITH TUMOR,,,4068,FEMALE,24,C71.0,Central nervous system,Low-grade gliomas
125,c0d47e0f-4918-4e06-9db6-201671b1259c,Bevacizumab,Targeted Molecular therapy,Dead,WITH TUMOR,,,4068,FEMALE,24,C71.0,Central nervous system,Low-grade gliomas
126,9239a22e-80b1-49a2-b0d5-cbab7e415254,Temozolomide,Chemotherapy,Dead,WITH TUMOR,,,605,FEMALE,51,C71.0,Central nervous system,Low-grade gliomas
127,9239a22e-80b1-49a2-b0d5-cbab7e415254,Temozolomide,Chemotherapy,Dead,WITH TUMOR,,,605,FEMALE,51,C71.0,Central nervous system,Low-grade gliomas
128,9239a22e-80b1-49a2-b0d5-cbab7e415254,PS-341 Bortrezomib,Chemotherapy,Dead,WITH TUMOR,,,605,FEMALE,51,C71.0,Central nervous system,Low-grade gliomas
129,9239a22e-80b1-49a2-b0d5-cbab7e415254,Cilengitide,Chemotherapy,Dead,WITH TUMOR,,,605,FEMALE,51,C71.0,Central nervous system,Low-grade gliomas
130,c13a429c-99ea-478c-ae95-fa499b9ea9fa,Temozolomide,Chemotherapy,Dead,,,,512,FEMALE,59,C71.0,Central nervous system,Low-grade gliomas
131,c13a429c-99ea-478c-ae95-fa499b9ea9fa,Temozolomide,Chemotherapy,Dead,,,,512,FEMALE,59,C71.0,Central nervous system,Low-grade gliomas
132,c13a429c-99ea-478c-ae95-fa499b9ea9fa,Isotrectinoin (acccutane),,Dead,,,,512,FEMALE,59,C71.0,Central nervous system,Low-grade gliomas
133,70939245-41e0-4845-a473-5fef719b9828,Temozolomide,Chemotherapy,Dead,WITH TUMOR,,,2875,FEMALE,35,C71.0,Central nervous system,Low-grade gliomas
134,70939245-41e0-4845-a473-5fef719b9828,Temozolomide,Chemotherapy,Dead,WITH TUMOR,,,2875,FEMALE,35,C71.0,Central nervous system,Low-grade gliomas
135,70939245-41e0-4845-a473-5fef719b9828,Temozolomide,Chemotherapy,Dead,WITH TUMOR,,,2875,FEMALE,35,C71.0,Central nervous system,Low-grade gliomas
136,70939245-41e0-4845-a473-5fef719b9828,Afatinib,Chemotherapy,Dead,WITH TUMOR,,,2875,FEMALE,35,C71.0,Central nervous system,Low-grade gliomas
137,14375753-a69f-41e0-b910-2bb8e84cc43a,Capecitabine,Chemotherapy,Dead,,,,3470,FEMALE,23,C71.0,Central nervous system,Low-grade gliomas
138,14375753-a69f-41e0-b910-2bb8e84cc43a,Temozolomide,Chemotherapy,Dead,,,,3470,FEMALE,23,C71.0,Central nervous system,Low-grade gliomas
139,14375753-a69f-41e0-b910-2bb8e84cc43a,Celebrex,,Dead,,,,3470,FEMALE,23,C71.0,Central nervous system,Low-grade gliomas
140,14375753-a69f-41e0-b910-2bb8e84cc43a,Temozolomide,Chemotherapy,Dead,,,,3470,FEMALE,23,C71.0,Central nervous system,Low-grade gliomas
141,467a7e6a-8cba-4ef1-8afd-6c8eaccbc3df,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,,,MALE,56,C71.0,Central nervous system,Low-grade gliomas
142,cd69d509-a652-4257-a8d3-767296bbb4ec,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,,,MALE,25,C71.0,Central nervous system,Low-grade gliomas
143,cd69d509-a652-4257-a8d3-767296bbb4ec,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,,,MALE,25,C71.0,Central nervous system,Low-grade gliomas
144,215e117c-4d76-463c-8f8a-fd6a28d23929,Lomustine,Chemotherapy,Dead,WITH TUMOR,,,349,FEMALE,60,C71.0,Central nervous system,Low-grade gliomas
145,215e117c-4d76-463c-8f8a-fd6a28d23929,Vincristine,Chemotherapy,Dead,WITH TUMOR,,,349,FEMALE,60,C71.0,Central nervous system,Low-grade gliomas
146,215e117c-4d76-463c-8f8a-fd6a28d23929,Procarbazine,Chemotherapy,Dead,WITH TUMOR,,,349,FEMALE,60,C71.0,Central nervous system,Low-grade gliomas
147,427c40f6-d1bd-49f2-b303-a975793b937e,Lomustin,Chemotherapy,Alive,TUMOR FREE,,,,FEMALE,41,C71.0,Central nervous system,Low-grade gliomas
148,427c40f6-d1bd-49f2-b303-a975793b937e,Vincristine,Chemotherapy,Alive,TUMOR FREE,,,,FEMALE,41,C71.0,Central nervous system,Low-grade gliomas
149,427c40f6-d1bd-49f2-b303-a975793b937e,Procarbazine,Chemotherapy,Alive,TUMOR FREE,,,,FEMALE,41,C71.0,Central nervous system,Low-grade gliomas
150,01c4ca12-ac08-41dd-9e4f-bfb0971688a2,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,,,FEMALE,32,C71.0,Central nervous system,Low-grade gliomas
151,834e560a-a506-456d-baf2-a206ca058153,Temozolomide,Chemotherapy,Dead,WITH TUMOR,,,456,FEMALE,58,C71.0,Central nervous system,Low-grade gliomas
152,834e560a-a506-456d-baf2-a206ca058153,Temozolomide,Chemotherapy,Dead,WITH TUMOR,,,456,FEMALE,58,C71.0,Central nervous system,Low-grade gliomas
153,d61b5d20-4d6d-4fdc-afe8-4b100b686eda,Temozolomide,Chemotherapy,Dead,WITH TUMOR,,,269,MALE,59,C71.0,Central nervous system,Low-grade gliomas
154,ec82a00f-3909-4781-8ae2-e54cbc1ac7ac,Bevacizumab,Targeted Molecular therapy,Alive,WITH TUMOR,,,,FEMALE,41,C71.0,Central nervous system,Low-grade gliomas
155,ec82a00f-3909-4781-8ae2-e54cbc1ac7ac,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,,,FEMALE,41,C71.0,Central nervous system,Low-grade gliomas
156,ec82a00f-3909-4781-8ae2-e54cbc1ac7ac,Irinotecan,Chemotherapy,Alive,WITH TUMOR,,,,FEMALE,41,C71.0,Central nervous system,Low-grade gliomas
157,f18dab99-26b0-4727-89a9-7f16bd382356,Temozolomide,Chemotherapy,Dead,WITH TUMOR,,,933,FEMALE,57,C71.0,Central nervous system,Low-grade gliomas
158,f18dab99-26b0-4727-89a9-7f16bd382356,Temozolomide,Chemotherapy,Dead,WITH TUMOR,,,933,FEMALE,57,C71.0,Central nervous system,Low-grade gliomas
159,1b43ff0c-cf13-4620-b5c7-7abd9129612f,Temozolomide,Chemotherapy,Alive,TUMOR FREE,,,,MALE,39,C71.0,Central nervous system,Low-grade gliomas
160,1b43ff0c-cf13-4620-b5c7-7abd9129612f,Temozolomide,Chemotherapy,Alive,TUMOR FREE,,,,MALE,39,C71.0,Central nervous system,Low-grade gliomas
161,145f87a3-5e86-4a87-8e49-b166a2271d02,Tomaxifen,Chemotherapy,Dead,WITH TUMOR,,,242,MALE,69,C71.0,Central nervous system,Low-grade gliomas
162,145f87a3-5e86-4a87-8e49-b166a2271d02,Procarbazine,Chemotherapy,Dead,WITH TUMOR,,,242,MALE,69,C71.0,Central nervous system,Low-grade gliomas
163,292cf158-dd47-44a1-912b-73626095a0f7,Temozolomide,Chemotherapy,Dead,WITH TUMOR,,,576,FEMALE,38,C71.0,Central nervous system,Low-grade gliomas
164,292cf158-dd47-44a1-912b-73626095a0f7,Temozolomide,Chemotherapy,Dead,WITH TUMOR,,,576,FEMALE,38,C71.0,Central nervous system,Low-grade gliomas
165,81622da8-9f36-4ea3-b223-d831d8c10f87,Temozolomide,Chemotherapy,Dead,WITH TUMOR,,,1339,MALE,33,C71.0,Central nervous system,Low-grade gliomas
166,81622da8-9f36-4ea3-b223-d831d8c10f87,Bevacizumab,Targeted Molecular therapy,Dead,WITH TUMOR,,,1339,MALE,33,C71.0,Central nervous system,Low-grade gliomas
167,81622da8-9f36-4ea3-b223-d831d8c10f87,Irinotecan,Chemotherapy,Dead,WITH TUMOR,,,1339,MALE,33,C71.0,Central nervous system,Low-grade gliomas
168,81622da8-9f36-4ea3-b223-d831d8c10f87,Temozolomide,Chemotherapy,Dead,WITH TUMOR,,,1339,MALE,33,C71.0,Central nervous system,Low-grade gliomas
169,81622da8-9f36-4ea3-b223-d831d8c10f87,Temozolomide,Chemotherapy,Dead,WITH TUMOR,,,1339,MALE,33,C71.0,Central nervous system,Low-grade gliomas
170,a144e4e4-2877-4340-a2bf-524adbde8bc8,Temozolomide,Chemotherapy,Dead,WITH TUMOR,,,1886,FEMALE,53,C71.0,Central nervous system,Low-grade gliomas
171,a144e4e4-2877-4340-a2bf-524adbde8bc8,Temozolomide,Chemotherapy,Dead,WITH TUMOR,,,1886,FEMALE,53,C71.0,Central nervous system,Low-grade gliomas
172,a144e4e4-2877-4340-a2bf-524adbde8bc8,Bevacizumab,Targeted Molecular therapy,Dead,WITH TUMOR,,,1886,FEMALE,53,C71.0,Central nervous system,Low-grade gliomas
173,a144e4e4-2877-4340-a2bf-524adbde8bc8,Irintotecan,Chemotherapy,Dead,WITH TUMOR,,,1886,FEMALE,53,C71.0,Central nervous system,Low-grade gliomas
174,a144e4e4-2877-4340-a2bf-524adbde8bc8,Temozolomide,Chemotherapy,Dead,WITH TUMOR,,,1886,FEMALE,53,C71.0,Central nervous system,Low-grade gliomas
175,84ae73e4-3b39-4444-9bfb-3fc6057eab32,Temozolomide,Chemotherapy,Dead,WITH TUMOR,,,788,MALE,53,C71.0,Central nervous system,Low-grade gliomas
176,84ae73e4-3b39-4444-9bfb-3fc6057eab32,Temozlomide,Chemotherapy,Dead,WITH TUMOR,,,788,MALE,53,C71.0,Central nervous system,Low-grade gliomas
177,84ae73e4-3b39-4444-9bfb-3fc6057eab32,Irinotecan,Chemotherapy,Dead,WITH TUMOR,,,788,MALE,53,C71.0,Central nervous system,Low-grade gliomas
178,84ae73e4-3b39-4444-9bfb-3fc6057eab32,Temozolomide,Chemotherapy,Dead,WITH TUMOR,,,788,MALE,53,C71.0,Central nervous system,Low-grade gliomas
179,84ae73e4-3b39-4444-9bfb-3fc6057eab32,Bevacizumab,Targeted Molecular therapy,Dead,WITH TUMOR,,,788,MALE,53,C71.0,Central nervous system,Low-grade gliomas
180,5a769292-c3ce-4e18-b821-2bfe0e24978c,Bevacizumab,Targeted Molecular therapy,Alive,WITH TUMOR,,,,FEMALE,48,C71.0,Central nervous system,Low-grade gliomas
181,5a769292-c3ce-4e18-b821-2bfe0e24978c,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,,,FEMALE,48,C71.0,Central nervous system,Low-grade gliomas
182,5a769292-c3ce-4e18-b821-2bfe0e24978c,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,,,FEMALE,48,C71.0,Central nervous system,Low-grade gliomas
183,d61710c1-8ac3-44e3-b567-66288a6ab731,Bevacizumab,Targeted Molecular therapy,Dead,WITH TUMOR,,,709,MALE,43,C71.0,Central nervous system,Low-grade gliomas
184,d61710c1-8ac3-44e3-b567-66288a6ab731,Irinotecan,Chemotherapy,Dead,WITH TUMOR,,,709,MALE,43,C71.0,Central nervous system,Low-grade gliomas
185,d61710c1-8ac3-44e3-b567-66288a6ab731,Temozolomide,Chemotherapy,Dead,WITH TUMOR,,,709,MALE,43,C71.0,Central nervous system,Low-grade gliomas
186,d61710c1-8ac3-44e3-b567-66288a6ab731,Temozolomide,Chemotherapy,Dead,WITH TUMOR,,,709,MALE,43,C71.0,Central nervous system,Low-grade gliomas
187,c35f36b1-ba3d-4eea-bf5a-c95480202176,temozolomide,Chemotherapy,Alive,WITH TUMOR,,,,MALE,67,C71.0,Central nervous system,Low-grade gliomas
188,c35f36b1-ba3d-4eea-bf5a-c95480202176,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,,,MALE,67,C71.0,Central nervous system,Low-grade gliomas
189,c35f36b1-ba3d-4eea-bf5a-c95480202176,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,,,MALE,67,C71.0,Central nervous system,Low-grade gliomas
190,ca427acb-034e-42e2-961a-b9d5dc30b741,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,,,FEMALE,41,C71.0,Central nervous system,Low-grade gliomas
191,b8df1577-2a75-4eb7-ab27-f2dd76160730,Temozolomide,Chemotherapy,Dead,WITH TUMOR,,,155,FEMALE,57,C71.0,Central nervous system,Low-grade gliomas
192,b9a3b647-61b3-4d98-90ca-e307ab50984a,Temozolomide,Chemotherapy,Dead,WITH TUMOR,,Stable Disease,722,FEMALE,63,C71.0,Central nervous system,Low-grade gliomas
193,b9a3b647-61b3-4d98-90ca-e307ab50984a,Temozolomide,Chemotherapy,Dead,WITH TUMOR,,Clinical Progressive Disease,722,FEMALE,63,C71.0,Central nervous system,Low-grade gliomas
194,b9a3b647-61b3-4d98-90ca-e307ab50984a,Irinotecan,Chemotherapy,Dead,WITH TUMOR,,Stable Disease,722,FEMALE,63,C71.0,Central nervous system,Low-grade gliomas
195,b9a3b647-61b3-4d98-90ca-e307ab50984a,Bevacizumab,Targeted Molecular therapy,Dead,WITH TUMOR,,Clinical Progressive Disease,722,FEMALE,63,C71.0,Central nervous system,Low-grade gliomas
196,6fab9c30-354b-4f99-9b60-6823c12b9b0a,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,Stable Disease,,FEMALE,61,C71.0,Central nervous system,Low-grade gliomas
197,6fab9c30-354b-4f99-9b60-6823c12b9b0a,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,,,FEMALE,61,C71.0,Central nervous system,Low-grade gliomas
198,c81d4681-c02f-4b33-abe0-b6ad7d61194d,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,Stable Disease,,MALE,29,C71.0,Central nervous system,Low-grade gliomas
199,c81d4681-c02f-4b33-abe0-b6ad7d61194d,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,,,MALE,29,C71.0,Central nervous system,Low-grade gliomas
200,c81d4681-c02f-4b33-abe0-b6ad7d61194d,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,,,MALE,29,C71.0,Central nervous system,Low-grade gliomas
201,f97a9afe-e54a-4ef0-b458-0c77f938552e,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,,,MALE,51,C71.0,Central nervous system,Low-grade gliomas
202,11dffe71-b516-41e8-9987-e0ff5d2356d1,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,Stable Disease,,FEMALE,60,C71.0,Central nervous system,Low-grade gliomas
203,11dffe71-b516-41e8-9987-e0ff5d2356d1,temozolomide,Chemotherapy,Alive,WITH TUMOR,,,,FEMALE,60,C71.0,Central nervous system,Low-grade gliomas
204,e488f613-f155-4e11-87d4-8c789ea81691,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,Clinical Progressive Disease,,FEMALE,29,C71.0,Central nervous system,Low-grade gliomas
205,e488f613-f155-4e11-87d4-8c789ea81691,Lomustine,Chemotherapy,Alive,WITH TUMOR,,Stable Disease,,FEMALE,29,C71.0,Central nervous system,Low-grade gliomas
206,e488f613-f155-4e11-87d4-8c789ea81691,Procarbazine,Chemotherapy,Alive,WITH TUMOR,,Stable Disease,,FEMALE,29,C71.0,Central nervous system,Low-grade gliomas
207,fc8828ae-484d-4fc8-a168-f8bc58ad65b9,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,Stable Disease,,FEMALE,55,C71.0,Central nervous system,Low-grade gliomas
208,fc8828ae-484d-4fc8-a168-f8bc58ad65b9,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,,,FEMALE,55,C71.0,Central nervous system,Low-grade gliomas
209,669605F6-39A1-4F8C-81DC-39430FF5F892,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,,,MALE,33,C71.0,Central nervous system,Low-grade gliomas
210,669605F6-39A1-4F8C-81DC-39430FF5F892,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,Stable Disease,,MALE,33,C71.0,Central nervous system,Low-grade gliomas
211,4BD8EBC1-6F6E-44A2-8544-106901A7BAE5,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,,,MALE,51,C71.0,Central nervous system,Low-grade gliomas
212,DD163547-43AD-4FE4-873E-83C4C6BE4465,Temodar,Chemotherapy,Alive,TUMOR FREE,Stable Disease,Stable Disease,,MALE,42,C71.0,Central nervous system,Low-grade gliomas
213,699D3BA1-94C8-409F-90C3-E7FE2F1CF825,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,,,MALE,70,C71.0,Central nervous system,Low-grade gliomas
214,1C095C4A-DF97-402E-902C-FC83BCF8EF88,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,Stable Disease,,FEMALE,62,C71.0,Central nervous system,Low-grade gliomas
215,0167CF11-74BE-4701-AB9A-4E057D4BB545,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,Stable Disease,,FEMALE,46,C71.0,Central nervous system,Low-grade gliomas
216,0167CF11-74BE-4701-AB9A-4E057D4BB545,Temozolomide,,Alive,WITH TUMOR,,Stable Disease,,FEMALE,46,C71.0,Central nervous system,Low-grade gliomas
217,0167CF11-74BE-4701-AB9A-4E057D4BB545,Mibefradil,Chemotherapy,Alive,WITH TUMOR,,Clinical Progressive Disease,,FEMALE,46,C71.0,Central nervous system,Low-grade gliomas
218,0167CF11-74BE-4701-AB9A-4E057D4BB545,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,Clinical Progressive Disease,,FEMALE,46,C71.0,Central nervous system,Low-grade gliomas
219,0167CF11-74BE-4701-AB9A-4E057D4BB545,Lomustine,Chemotherapy,Alive,WITH TUMOR,,Clinical Progressive Disease,,FEMALE,46,C71.0,Central nervous system,Low-grade gliomas
220,0167CF11-74BE-4701-AB9A-4E057D4BB545,Procarbazine,Chemotherapy,Alive,WITH TUMOR,,Clinical Progressive Disease,,FEMALE,46,C71.0,Central nervous system,Low-grade gliomas
221,0167CF11-74BE-4701-AB9A-4E057D4BB545,bevacizumab,Targeted Molecular therapy,Alive,WITH TUMOR,,Clinical Progressive Disease,,FEMALE,46,C71.0,Central nervous system,Low-grade gliomas
222,3BAA0015-885C-487A-9076-236F404FEB3E,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,Stable Disease,,FEMALE,35,C71.0,Central nervous system,Low-grade gliomas
223,3BAA0015-885C-487A-9076-236F404FEB3E,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,,,FEMALE,35,C71.0,Central nervous system,Low-grade gliomas
224,3BAA0015-885C-487A-9076-236F404FEB3E,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,Stable Disease,,FEMALE,35,C71.0,Central nervous system,Low-grade gliomas
225,A56C2083-33D5-4C98-B85F-3B68A3D80ADD,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,Stable Disease,,FEMALE,27,C71.0,Central nervous system,Low-grade gliomas
226,A56C2083-33D5-4C98-B85F-3B68A3D80ADD,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,,,FEMALE,27,C71.0,Central nervous system,Low-grade gliomas
227,A56C2083-33D5-4C98-B85F-3B68A3D80ADD,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,Stable Disease,,FEMALE,27,C71.0,Central nervous system,Low-grade gliomas
228,9CD3B3C6-2268-4E43-964B-B7A4DAF6FC6F,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,,,FEMALE,74,C71.0,Central nervous system,Low-grade gliomas
229,30BF5895-0671-4FB1-A96D-857847FCF7B0,Temozolomide,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,347,MALE,87,C71.0,Central nervous system,Low-grade gliomas
230,395798C5-3136-4A30-8557-A67A3ABDECAF,Temozolomide,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Stable Disease,814,MALE,54,C71.0,Central nervous system,Low-grade gliomas
231,395798C5-3136-4A30-8557-A67A3ABDECAF,Temozolomide,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,814,MALE,54,C71.0,Central nervous system,Low-grade gliomas
232,395798C5-3136-4A30-8557-A67A3ABDECAF,Procarbazine,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,814,MALE,54,C71.0,Central nervous system,Low-grade gliomas
233,395798C5-3136-4A30-8557-A67A3ABDECAF,Cilengtide,Targeted Molecular therapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,814,MALE,54,C71.0,Central nervous system,Low-grade gliomas
234,C56FA247-AD97-4DCE-A2D3-9BDFC5DC7B1B,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,Stable Disease,,MALE,30,C71.0,Central nervous system,Low-grade gliomas
235,C56FA247-AD97-4DCE-A2D3-9BDFC5DC7B1B,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,,,MALE,30,C71.0,Central nervous system,Low-grade gliomas
236,823F571A-3CFD-465D-95FD-187A398CCF6F,Temozolomide,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,648,MALE,51,C71.0,Central nervous system,Low-grade gliomas
237,04E6E843-7F31-43DA-B111-280CE2BD1949,Temozolomide,Chemotherapy,Alive,WITH TUMOR,Stable Disease,Stable Disease,,MALE,35,C71.0,Central nervous system,Low-grade gliomas
238,04E6E843-7F31-43DA-B111-280CE2BD1949,Temozolomide,Chemotherapy,Alive,WITH TUMOR,Stable Disease,Stable Disease,,MALE,35,C71.0,Central nervous system,Low-grade gliomas
239,04E6E843-7F31-43DA-B111-280CE2BD1949,Temozolomide,Chemotherapy,Alive,WITH TUMOR,Stable Disease,Clinical Progressive Disease,,MALE,35,C71.0,Central nervous system,Low-grade gliomas
240,04E6E843-7F31-43DA-B111-280CE2BD1949,Temozolomide,Chemotherapy,Alive,WITH TUMOR,Stable Disease,Clinical Progressive Disease,,MALE,35,C71.0,Central nervous system,Low-grade gliomas
241,04E6E843-7F31-43DA-B111-280CE2BD1949,Lomustine (CCNU),Chemotherapy,Alive,WITH TUMOR,Stable Disease,Clinical Progressive Disease,,MALE,35,C71.0,Central nervous system,Low-grade gliomas
242,04E6E843-7F31-43DA-B111-280CE2BD1949,bevacizumab,Targeted Molecular therapy,Alive,WITH TUMOR,Stable Disease,Clinical Progressive Disease,,MALE,35,C71.0,Central nervous system,Low-grade gliomas
243,EF12BFB7-4147-407F-84E9-586DBB10D583,Temozolomide,Chemotherapy,Alive,TUMOR FREE,Stable Disease,Stable Disease,,MALE,32,C71.0,Central nervous system,Low-grade gliomas
244,EF12BFB7-4147-407F-84E9-586DBB10D583,Temozolomide,Chemotherapy,Alive,TUMOR FREE,Stable Disease,Stable Disease,,MALE,32,C71.0,Central nervous system,Low-grade gliomas
245,D3D8987D-0A54-45F8-B9C9-17EC89FA864E,Temozolomide,Chemotherapy,Alive,TUMOR FREE,Progressive Disease,Clinical Progressive Disease,,MALE,56,C71.0,Central nervous system,Low-grade gliomas
246,D3D8987D-0A54-45F8-B9C9-17EC89FA864E,Temozolomide,Chemotherapy,Alive,TUMOR FREE,Progressive Disease,Stable Disease,,MALE,56,C71.0,Central nervous system,Low-grade gliomas
247,D3D8987D-0A54-45F8-B9C9-17EC89FA864E,Temozolomide,Chemotherapy,Alive,TUMOR FREE,Progressive Disease,Stable Disease,,MALE,56,C71.0,Central nervous system,Low-grade gliomas
248,E349D8AA-BB82-4CE8-B14C-61216289F25B,Temozolomide,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Stable Disease,228,MALE,52,C71.0,Central nervous system,Low-grade gliomas
249,E349D8AA-BB82-4CE8-B14C-61216289F25B,Temozolomide,Immunotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,228,MALE,52,C71.0,Central nervous system,Low-grade gliomas
250,62EC50E7-636E-46C6-AFED-66BF217B59C1,Temozolomide,Chemotherapy,Dead,,,,1351,MALE,40,C71.0,Central nervous system,Low-grade gliomas
251,0EFAF8F9-177C-4FFB-B03F-F0316ADF5DC1,SU101,,Dead,WITH TUMOR,Progressive Disease,Stable Disease,1183,MALE,32,C71.0,Central nervous system,Low-grade gliomas
252,0EFAF8F9-177C-4FFB-B03F-F0316ADF5DC1,ONYX-015,,Dead,WITH TUMOR,Progressive Disease,Stable Disease,1183,MALE,32,C71.0,Central nervous system,Low-grade gliomas
253,0EFAF8F9-177C-4FFB-B03F-F0316ADF5DC1,Temozolomide,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,1183,MALE,32,C71.0,Central nervous system,Low-grade gliomas
254,0EFAF8F9-177C-4FFB-B03F-F0316ADF5DC1,cis-retinoic acid,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,1183,MALE,32,C71.0,Central nervous system,Low-grade gliomas
255,0EFAF8F9-177C-4FFB-B03F-F0316ADF5DC1,Carmustine (BCNU),Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,1183,MALE,32,C71.0,Central nervous system,Low-grade gliomas
256,837b51d0-e6b7-431b-a5f3-7615bdf12b67,Procarbazine,Chemotherapy,Dead,WITH TUMOR,,,1525,MALE,41,C71.9,Central nervous system,Low-grade gliomas
257,837b51d0-e6b7-431b-a5f3-7615bdf12b67,CPT-11,Chemotherapy,Dead,WITH TUMOR,,,1525,MALE,41,C71.9,Central nervous system,Low-grade gliomas
258,837b51d0-e6b7-431b-a5f3-7615bdf12b67,Tamoxifen,Hormone Therapy,Dead,WITH TUMOR,,,1525,MALE,41,C71.9,Central nervous system,Low-grade gliomas
259,837b51d0-e6b7-431b-a5f3-7615bdf12b67,Vincristine,Chemotherapy,Dead,WITH TUMOR,,,1525,MALE,41,C71.9,Central nervous system,Low-grade gliomas
260,837b51d0-e6b7-431b-a5f3-7615bdf12b67,Tamoxifen,Hormone Therapy,Dead,WITH TUMOR,,,1525,MALE,41,C71.9,Central nervous system,Low-grade gliomas
261,837b51d0-e6b7-431b-a5f3-7615bdf12b67,CCNU,Chemotherapy,Dead,WITH TUMOR,,,1525,MALE,41,C71.9,Central nervous system,Low-grade gliomas
262,837b51d0-e6b7-431b-a5f3-7615bdf12b67,CCNU,Chemotherapy,Dead,WITH TUMOR,,,1525,MALE,41,C71.9,Central nervous system,Low-grade gliomas
263,837b51d0-e6b7-431b-a5f3-7615bdf12b67,Temozolomide,Chemotherapy,Dead,WITH TUMOR,,,1525,MALE,41,C71.9,Central nervous system,Low-grade gliomas
264,837b51d0-e6b7-431b-a5f3-7615bdf12b67,Procarbazine,Chemotherapy,Dead,WITH TUMOR,,,1525,MALE,41,C71.9,Central nervous system,Low-grade gliomas
265,837b51d0-e6b7-431b-a5f3-7615bdf12b67,CCNU,Chemotherapy,Dead,WITH TUMOR,,,1525,MALE,41,C71.9,Central nervous system,Low-grade gliomas
266,837b51d0-e6b7-431b-a5f3-7615bdf12b67,Celebrex,,Dead,WITH TUMOR,,,1525,MALE,41,C71.9,Central nervous system,Low-grade gliomas
267,837b51d0-e6b7-431b-a5f3-7615bdf12b67,Temozolomide,Chemotherapy,Dead,WITH TUMOR,,,1525,MALE,41,C71.9,Central nervous system,Low-grade gliomas
268,837b51d0-e6b7-431b-a5f3-7615bdf12b67,Vincristine,Chemotherapy,Dead,WITH TUMOR,,,1525,MALE,41,C71.9,Central nervous system,Low-grade gliomas
269,44a5c3b4-62a7-407b-b492-7069e1a43a26,Tamoxifen,Hormone Therapy,Dead,WITH TUMOR,,,2052,MALE,38,C71.9,Central nervous system,Low-grade gliomas
270,44a5c3b4-62a7-407b-b492-7069e1a43a26,Temozolomide,Chemotherapy,Dead,WITH TUMOR,,,2052,MALE,38,C71.9,Central nervous system,Low-grade gliomas
271,44a5c3b4-62a7-407b-b492-7069e1a43a26,CCNU,Chemotherapy,Dead,WITH TUMOR,,,2052,MALE,38,C71.9,Central nervous system,Low-grade gliomas
272,691d5202-90cc-4e08-83a3-0620a89d3a4b,Temozolomide,Chemotherapy,Dead,WITH TUMOR,,,1251,MALE,42,C71.9,Central nervous system,Low-grade gliomas
273,691d5202-90cc-4e08-83a3-0620a89d3a4b,Temozolomide,Chemotherapy,Dead,WITH TUMOR,,,1251,MALE,42,C71.9,Central nervous system,Low-grade gliomas
274,691d5202-90cc-4e08-83a3-0620a89d3a4b,CCNU,Chemotherapy,Dead,WITH TUMOR,,,1251,MALE,42,C71.9,Central nervous system,Low-grade gliomas
275,691d5202-90cc-4e08-83a3-0620a89d3a4b,Temozolomide,Chemotherapy,Dead,WITH TUMOR,,,1251,MALE,42,C71.9,Central nervous system,Low-grade gliomas
276,691d5202-90cc-4e08-83a3-0620a89d3a4b,CPT-11,Chemotherapy,Dead,WITH TUMOR,,,1251,MALE,42,C71.9,Central nervous system,Low-grade gliomas
277,691d5202-90cc-4e08-83a3-0620a89d3a4b,CCNU,Chemotherapy,Dead,WITH TUMOR,,,1251,MALE,42,C71.9,Central nervous system,Low-grade gliomas
278,691d5202-90cc-4e08-83a3-0620a89d3a4b,VP-16,Chemotherapy,Dead,WITH TUMOR,,,1251,MALE,42,C71.9,Central nervous system,Low-grade gliomas
279,691d5202-90cc-4e08-83a3-0620a89d3a4b,Temozolomide,Chemotherapy,Dead,WITH TUMOR,,,1251,MALE,42,C71.9,Central nervous system,Low-grade gliomas
280,a0bc5147-d9b4-41fd-8df3-a241d23722e8,CCNU,Chemotherapy,Dead,WITH TUMOR,,,2433,MALE,34,C71.9,Central nervous system,Low-grade gliomas
281,a0bc5147-d9b4-41fd-8df3-a241d23722e8,VP-16,Chemotherapy,Dead,WITH TUMOR,,,2433,MALE,34,C71.9,Central nervous system,Low-grade gliomas
282,a0bc5147-d9b4-41fd-8df3-a241d23722e8,Topotecan,Chemotherapy,Dead,WITH TUMOR,,,2433,MALE,34,C71.9,Central nervous system,Low-grade gliomas
283,a0bc5147-d9b4-41fd-8df3-a241d23722e8,Temozolomide,Chemotherapy,Dead,WITH TUMOR,,,2433,MALE,34,C71.9,Central nervous system,Low-grade gliomas
284,a0bc5147-d9b4-41fd-8df3-a241d23722e8,Hydroyurea,Chemotherapy,Dead,WITH TUMOR,,,2433,MALE,34,C71.9,Central nervous system,Low-grade gliomas
285,a0bc5147-d9b4-41fd-8df3-a241d23722e8,Temozolomide,Chemotherapy,Dead,WITH TUMOR,,,2433,MALE,34,C71.9,Central nervous system,Low-grade gliomas
286,a0bc5147-d9b4-41fd-8df3-a241d23722e8,Gleevec,Targeted Molecular therapy,Dead,WITH TUMOR,,,2433,MALE,34,C71.9,Central nervous system,Low-grade gliomas
287,a0bc5147-d9b4-41fd-8df3-a241d23722e8,CPT-11,Chemotherapy,Dead,WITH TUMOR,,,2433,MALE,34,C71.9,Central nervous system,Low-grade gliomas
288,a0bc5147-d9b4-41fd-8df3-a241d23722e8,Cytoxan,Chemotherapy,Dead,WITH TUMOR,,,2433,MALE,34,C71.9,Central nervous system,Low-grade gliomas
289,a0bc5147-d9b4-41fd-8df3-a241d23722e8,Avastin,Targeted Molecular therapy,Dead,WITH TUMOR,,,2433,MALE,34,C71.9,Central nervous system,Low-grade gliomas
290,a6ee311c-0a7b-4f47-86f1-f2164b128f9c,Temodar,Chemotherapy,Dead,WITH TUMOR,,,1762,FEMALE,62,C71.9,Central nervous system,Low-grade gliomas
291,a6ee311c-0a7b-4f47-86f1-f2164b128f9c,Temodar,Chemotherapy,Dead,WITH TUMOR,,,1762,FEMALE,62,C71.9,Central nervous system,Low-grade gliomas
292,a6ee311c-0a7b-4f47-86f1-f2164b128f9c,Temodar,Chemotherapy,Dead,WITH TUMOR,,,1762,FEMALE,62,C71.9,Central nervous system,Low-grade gliomas
293,a6ee311c-0a7b-4f47-86f1-f2164b128f9c,CCNU,Chemotherapy,Dead,WITH TUMOR,,,1762,FEMALE,62,C71.9,Central nervous system,Low-grade gliomas
294,a6ee311c-0a7b-4f47-86f1-f2164b128f9c,CCNu,Chemotherapy,Dead,WITH TUMOR,,,1762,FEMALE,62,C71.9,Central nervous system,Low-grade gliomas
295,a6ee311c-0a7b-4f47-86f1-f2164b128f9c,CCNU,Chemotherapy,Dead,WITH TUMOR,,,1762,FEMALE,62,C71.9,Central nervous system,Low-grade gliomas
296,a6ee311c-0a7b-4f47-86f1-f2164b128f9c,Temodar,Chemotherapy,Dead,WITH TUMOR,,,1762,FEMALE,62,C71.9,Central nervous system,Low-grade gliomas
297,a6ee311c-0a7b-4f47-86f1-f2164b128f9c,Temodar,Chemotherapy,Dead,WITH TUMOR,,,1762,FEMALE,62,C71.9,Central nervous system,Low-grade gliomas
298,a6ee311c-0a7b-4f47-86f1-f2164b128f9c,Celebrex,,Dead,WITH TUMOR,,,1762,FEMALE,62,C71.9,Central nervous system,Low-grade gliomas
299,0061e9ef-df6a-414e-af64-c88f8192e2d3,Temozolomide,Chemotherapy,Dead,WITH TUMOR,,,4084,MALE,31,C71.9,Central nervous system,Low-grade gliomas
300,0061e9ef-df6a-414e-af64-c88f8192e2d3,Celebrex,,Dead,WITH TUMOR,,,4084,MALE,31,C71.9,Central nervous system,Low-grade gliomas
301,0061e9ef-df6a-414e-af64-c88f8192e2d3,MAGI131-81c6,,Dead,WITH TUMOR,,,4084,MALE,31,C71.9,Central nervous system,Low-grade gliomas
302,0061e9ef-df6a-414e-af64-c88f8192e2d3,CCNU,Chemotherapy,Dead,WITH TUMOR,,,4084,MALE,31,C71.9,Central nervous system,Low-grade gliomas
303,0061e9ef-df6a-414e-af64-c88f8192e2d3,VP-16,Chemotherapy,Dead,WITH TUMOR,,,4084,MALE,31,C71.9,Central nervous system,Low-grade gliomas
304,0061e9ef-df6a-414e-af64-c88f8192e2d3,Karerltecin,Chemotherapy,Dead,WITH TUMOR,,,4084,MALE,31,C71.9,Central nervous system,Low-grade gliomas
305,0061e9ef-df6a-414e-af64-c88f8192e2d3,Cloretazine,Chemotherapy,Dead,WITH TUMOR,,,4084,MALE,31,C71.9,Central nervous system,Low-grade gliomas
306,0061e9ef-df6a-414e-af64-c88f8192e2d3,Tamoxifen,Hormone Therapy,Dead,WITH TUMOR,,,4084,MALE,31,C71.9,Central nervous system,Low-grade gliomas
307,400b2fa3-baf7-4baa-99b4-88b9f25b5049,CCNU,Chemotherapy,Dead,WITH TUMOR,,,2379,FEMALE,42,C71.9,Central nervous system,Low-grade gliomas
308,400b2fa3-baf7-4baa-99b4-88b9f25b5049,Gliadel Wafers,Chemotherapy,Dead,WITH TUMOR,,,2379,FEMALE,42,C71.9,Central nervous system,Low-grade gliomas
309,400b2fa3-baf7-4baa-99b4-88b9f25b5049,CPT-11,Chemotherapy,Dead,WITH TUMOR,,,2379,FEMALE,42,C71.9,Central nervous system,Low-grade gliomas
310,400b2fa3-baf7-4baa-99b4-88b9f25b5049,CPT-11,Chemotherapy,Dead,WITH TUMOR,,,2379,FEMALE,42,C71.9,Central nervous system,Low-grade gliomas
311,400b2fa3-baf7-4baa-99b4-88b9f25b5049,CCNU,Chemotherapy,Dead,WITH TUMOR,,,2379,FEMALE,42,C71.9,Central nervous system,Low-grade gliomas
312,400b2fa3-baf7-4baa-99b4-88b9f25b5049,Procarbazine,Chemotherapy,Dead,WITH TUMOR,,,2379,FEMALE,42,C71.9,Central nervous system,Low-grade gliomas
313,400b2fa3-baf7-4baa-99b4-88b9f25b5049,CCNU,Chemotherapy,Dead,WITH TUMOR,,,2379,FEMALE,42,C71.9,Central nervous system,Low-grade gliomas
314,400b2fa3-baf7-4baa-99b4-88b9f25b5049,Temazolomide,Chemotherapy,Dead,WITH TUMOR,,,2379,FEMALE,42,C71.9,Central nervous system,Low-grade gliomas
315,400b2fa3-baf7-4baa-99b4-88b9f25b5049,Cytoxan,Chemotherapy,Dead,WITH TUMOR,,,2379,FEMALE,42,C71.9,Central nervous system,Low-grade gliomas
316,400b2fa3-baf7-4baa-99b4-88b9f25b5049,Temozolomide,Chemotherapy,Dead,WITH TUMOR,,,2379,FEMALE,42,C71.9,Central nervous system,Low-grade gliomas
317,400b2fa3-baf7-4baa-99b4-88b9f25b5049,Carboplatin,Chemotherapy,Dead,WITH TUMOR,,,2379,FEMALE,42,C71.9,Central nervous system,Low-grade gliomas
318,400b2fa3-baf7-4baa-99b4-88b9f25b5049,Celebrex,,Dead,WITH TUMOR,,,2379,FEMALE,42,C71.9,Central nervous system,Low-grade gliomas
319,400b2fa3-baf7-4baa-99b4-88b9f25b5049,VP-16,Chemotherapy,Dead,WITH TUMOR,,,2379,FEMALE,42,C71.9,Central nervous system,Low-grade gliomas
320,400b2fa3-baf7-4baa-99b4-88b9f25b5049,Tamoxiten,Hormone Therapy,Dead,WITH TUMOR,,,2379,FEMALE,42,C71.9,Central nervous system,Low-grade gliomas
321,84569c1a-6baa-4380-ae3c-707df1be4618,Temodar,Chemotherapy,Dead,WITH TUMOR,,,2907,FEMALE,48,C71.9,Central nervous system,Low-grade gliomas
322,84569c1a-6baa-4380-ae3c-707df1be4618,Celebrex,,Dead,WITH TUMOR,,,2907,FEMALE,48,C71.9,Central nervous system,Low-grade gliomas
323,84569c1a-6baa-4380-ae3c-707df1be4618,Carboplatin,Chemotherapy,Dead,WITH TUMOR,,,2907,FEMALE,48,C71.9,Central nervous system,Low-grade gliomas
324,84569c1a-6baa-4380-ae3c-707df1be4618,Carboplatin,Chemotherapy,Dead,WITH TUMOR,,,2907,FEMALE,48,C71.9,Central nervous system,Low-grade gliomas
325,84569c1a-6baa-4380-ae3c-707df1be4618,CCNU,Chemotherapy,Dead,WITH TUMOR,,,2907,FEMALE,48,C71.9,Central nervous system,Low-grade gliomas
326,84569c1a-6baa-4380-ae3c-707df1be4618,Temodar,Chemotherapy,Dead,WITH TUMOR,,,2907,FEMALE,48,C71.9,Central nervous system,Low-grade gliomas
327,84569c1a-6baa-4380-ae3c-707df1be4618,CCNU,Chemotherapy,Dead,WITH TUMOR,,,2907,FEMALE,48,C71.9,Central nervous system,Low-grade gliomas
328,84569c1a-6baa-4380-ae3c-707df1be4618,VP-16,Chemotherapy,Dead,WITH TUMOR,,,2907,FEMALE,48,C71.9,Central nervous system,Low-grade gliomas
329,84569c1a-6baa-4380-ae3c-707df1be4618,VP-16,Chemotherapy,Dead,WITH TUMOR,,,2907,FEMALE,48,C71.9,Central nervous system,Low-grade gliomas
330,5ea230a6-77aa-4aa5-867c-09651d481d8b,Gliadel Wafer,Chemotherapy,Dead,,,,3978,FEMALE,38,C71.9,Central nervous system,Low-grade gliomas
331,457EC7F6-8612-4641-AAEF-8A7F2C44C30C,CCNU,Chemotherapy,Dead,WITH TUMOR,Stable Disease,Clinical Progressive Disease,435,MALE,57,C71.0,Central nervous system,Low-grade gliomas
332,457EC7F6-8612-4641-AAEF-8A7F2C44C30C,Temodar,Chemotherapy,Dead,WITH TUMOR,Stable Disease,,435,MALE,57,C71.0,Central nervous system,Low-grade gliomas
333,F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,CCNU,Chemotherapy,Dead,WITH TUMOR,Stable Disease,Clinical Progressive Disease,886,FEMALE,32,C71.0,Central nervous system,Low-grade gliomas
334,F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,CCNU,Chemotherapy,Dead,WITH TUMOR,Stable Disease,Clinical Progressive Disease,886,FEMALE,32,C71.0,Central nervous system,Low-grade gliomas
335,F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,Gliadel wafers,Chemotherapy,Dead,WITH TUMOR,Stable Disease,Stable Disease,886,FEMALE,32,C71.0,Central nervous system,Low-grade gliomas
336,F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,Temodar,,Dead,WITH TUMOR,Stable Disease,Clinical Progressive Disease,886,FEMALE,32,C71.0,Central nervous system,Low-grade gliomas
337,F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,Celebrex,Ancillary,Dead,WITH TUMOR,Stable Disease,Clinical Progressive Disease,886,FEMALE,32,C71.0,Central nervous system,Low-grade gliomas
338,F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,Temodar,Chemotherapy,Dead,WITH TUMOR,Stable Disease,Clinical Progressive Disease,886,FEMALE,32,C71.0,Central nervous system,Low-grade gliomas
339,F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,Benzylguanine,Targeted Molecular therapy,Dead,WITH TUMOR,Stable Disease,Clinical Progressive Disease,886,FEMALE,32,C71.0,Central nervous system,Low-grade gliomas
340,F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,Karenitecin,Chemotherapy,Dead,WITH TUMOR,Stable Disease,Clinical Progressive Disease,886,FEMALE,32,C71.0,Central nervous system,Low-grade gliomas
341,F842F756-CE78-4C99-BCF8-3BCE18A4D9EF,VP-16,Chemotherapy,Dead,WITH TUMOR,Stable Disease,Clinical Progressive Disease,886,FEMALE,32,C71.0,Central nervous system,Low-grade gliomas
342,9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7,Temodar,Chemotherapy,Dead,WITH TUMOR,Stable Disease,Stable Disease,2835,FEMALE,47,C71.0,Central nervous system,Low-grade gliomas
343,9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7,CCNU,Chemotherapy,Dead,WITH TUMOR,Stable Disease,Stable Disease,2835,FEMALE,47,C71.0,Central nervous system,Low-grade gliomas
344,9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7,Temodar,Chemotherapy,Dead,WITH TUMOR,Stable Disease,,2835,FEMALE,47,C71.0,Central nervous system,Low-grade gliomas
345,9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7,Temodar,Chemotherapy,Dead,WITH TUMOR,Stable Disease,Clinical Progressive Disease,2835,FEMALE,47,C71.0,Central nervous system,Low-grade gliomas
346,9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7,Temodar,Chemotherapy,Dead,WITH TUMOR,Stable Disease,Clinical Progressive Disease,2835,FEMALE,47,C71.0,Central nervous system,Low-grade gliomas
347,9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7,Erlotinib,Chemotherapy,Dead,WITH TUMOR,Stable Disease,Stable Disease,2835,FEMALE,47,C71.0,Central nervous system,Low-grade gliomas
348,9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7,Avastin,,Dead,WITH TUMOR,Stable Disease,Stable Disease,2835,FEMALE,47,C71.0,Central nervous system,Low-grade gliomas
349,9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7,Avastin,,Dead,WITH TUMOR,Stable Disease,Clinical Progressive Disease,2835,FEMALE,47,C71.0,Central nervous system,Low-grade gliomas
350,9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7,VP-16,Chemotherapy,Dead,WITH TUMOR,Stable Disease,Clinical Progressive Disease,2835,FEMALE,47,C71.0,Central nervous system,Low-grade gliomas
351,BC6FBB3C-870D-40B5-983B-7C88705E020D,Temodar,Chemotherapy,Dead,WITH TUMOR,Stable Disease,Stable Disease,592,MALE,55,C71.0,Central nervous system,Low-grade gliomas
352,BC6FBB3C-870D-40B5-983B-7C88705E020D,CPT-11,Chemotherapy,Dead,WITH TUMOR,Stable Disease,Stable Disease,592,MALE,55,C71.0,Central nervous system,Low-grade gliomas
353,BC6FBB3C-870D-40B5-983B-7C88705E020D,Avastin,Immunotherapy,Dead,WITH TUMOR,Stable Disease,Clinical Progressive Disease,592,MALE,55,C71.0,Central nervous system,Low-grade gliomas
354,BC6FBB3C-870D-40B5-983B-7C88705E020D,Temodar,Chemotherapy,Dead,WITH TUMOR,Stable Disease,Clinical Progressive Disease,592,MALE,55,C71.0,Central nervous system,Low-grade gliomas
355,BC6FBB3C-870D-40B5-983B-7C88705E020D,MR1-1,Immunotherapy,Dead,WITH TUMOR,Stable Disease,Clinical Progressive Disease,592,MALE,55,C71.0,Central nervous system,Low-grade gliomas
356,BB4A30D5-4EBA-45DB-B05A-BD843044D508,Temodar,Chemotherapy,Dead,,Stable Disease,Stable Disease,378,MALE,52,C71.0,Central nervous system,Low-grade gliomas
357,BB4A30D5-4EBA-45DB-B05A-BD843044D508,Temodar,Chemotherapy,Dead,,Stable Disease,,378,MALE,52,C71.0,Central nervous system,Low-grade gliomas
358,96D9249E-501C-49E0-9559-01DA978A9CA6,Temodar,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,492,MALE,46,C71.0,Central nervous system,Low-grade gliomas
359,96D9249E-501C-49E0-9559-01DA978A9CA6,Avastin,Immunotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,492,MALE,46,C71.0,Central nervous system,Low-grade gliomas
360,96D9249E-501C-49E0-9559-01DA978A9CA6,Carboplatin,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,492,MALE,46,C71.0,Central nervous system,Low-grade gliomas
361,96D9249E-501C-49E0-9559-01DA978A9CA6,CPT-11,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,492,MALE,46,C71.0,Central nervous system,Low-grade gliomas
362,96D9249E-501C-49E0-9559-01DA978A9CA6,Avastin,Immunotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,492,MALE,46,C71.0,Central nervous system,Low-grade gliomas
363,96D9249E-501C-49E0-9559-01DA978A9CA6,VP-16,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,492,MALE,46,C71.0,Central nervous system,Low-grade gliomas
364,4250AC3C-C8B0-46CE-B9C8-7963BC386041,Temodar,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,648,MALE,63,C71.0,Central nervous system,Low-grade gliomas
365,4250AC3C-C8B0-46CE-B9C8-7963BC386041,Avastin,Immunotherapy,Dead,WITH TUMOR,Progressive Disease,Stable Disease,648,MALE,63,C71.0,Central nervous system,Low-grade gliomas
366,4250AC3C-C8B0-46CE-B9C8-7963BC386041,CPT-11,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Stable Disease,648,MALE,63,C71.0,Central nervous system,Low-grade gliomas
367,4250AC3C-C8B0-46CE-B9C8-7963BC386041,Avastin,Immunotherapy,Dead,WITH TUMOR,Progressive Disease,Stable Disease,648,MALE,63,C71.0,Central nervous system,Low-grade gliomas
368,4250AC3C-C8B0-46CE-B9C8-7963BC386041,VP-16,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Stable Disease,648,MALE,63,C71.0,Central nervous system,Low-grade gliomas
369,4250AC3C-C8B0-46CE-B9C8-7963BC386041,Avastin,Immunotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,648,MALE,63,C71.0,Central nervous system,Low-grade gliomas
370,4250AC3C-C8B0-46CE-B9C8-7963BC386041,Avastin,Immunotherapy,Dead,WITH TUMOR,Progressive Disease,Stable Disease,648,MALE,63,C71.0,Central nervous system,Low-grade gliomas
371,4250AC3C-C8B0-46CE-B9C8-7963BC386041,Carboplatin,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Stable Disease,648,MALE,63,C71.0,Central nervous system,Low-grade gliomas
372,BCC17E9A-6FE3-44FF-963C-D2D850A431F1,Temodar,Chemotherapy,Dead,WITH TUMOR,Stable Disease,Stable Disease,727,FEMALE,63,C71.0,Central nervous system,Low-grade gliomas
373,BCC17E9A-6FE3-44FF-963C-D2D850A431F1,Temodar,Chemotherapy,Dead,WITH TUMOR,Stable Disease,Clinical Progressive Disease,727,FEMALE,63,C71.0,Central nervous system,Low-grade gliomas
374,BCC17E9A-6FE3-44FF-963C-D2D850A431F1,Avastin,Immunotherapy,Dead,WITH TUMOR,Stable Disease,Clinical Progressive Disease,727,FEMALE,63,C71.0,Central nervous system,Low-grade gliomas
375,BCC17E9A-6FE3-44FF-963C-D2D850A431F1,Temodar,Chemotherapy,Dead,WITH TUMOR,Stable Disease,Clinical Progressive Disease,727,FEMALE,63,C71.0,Central nervous system,Low-grade gliomas
376,BCC17E9A-6FE3-44FF-963C-D2D850A431F1,Avastin,Immunotherapy,Dead,WITH TUMOR,Stable Disease,Clinical Progressive Disease,727,FEMALE,63,C71.0,Central nervous system,Low-grade gliomas
377,BCC17E9A-6FE3-44FF-963C-D2D850A431F1,CCNU,Chemotherapy,Dead,WITH TUMOR,Stable Disease,Clinical Progressive Disease,727,FEMALE,63,C71.0,Central nervous system,Low-grade gliomas
378,992452EE-8D9F-406B-9708-7BCB60062743,I131-81C6,Immunotherapy,Dead,WITH TUMOR,Stable Disease,Stable Disease,2282,MALE,45,C71.0,Central nervous system,Low-grade gliomas
379,75DBC8FB-4DB8-4764-824C-ECCF3A223884,Temodar,Chemotherapy,Dead,WITH TUMOR,Stable Disease,Stable Disease,1578,FEMALE,58,C71.0,Central nervous system,Low-grade gliomas
380,75DBC8FB-4DB8-4764-824C-ECCF3A223884,CCNU,Chemotherapy,Dead,WITH TUMOR,Stable Disease,Stable Disease,1578,FEMALE,58,C71.0,Central nervous system,Low-grade gliomas
381,75DBC8FB-4DB8-4764-824C-ECCF3A223884,Temodar,Chemotherapy,Dead,WITH TUMOR,Stable Disease,Clinical Progressive Disease,1578,FEMALE,58,C71.0,Central nervous system,Low-grade gliomas
382,5E2539E0-2088-43DF-AD2A-F854D8BB6D30,Temodar,Chemotherapy,Dead,WITH TUMOR,Stable Disease,Stable Disease,466,MALE,71,C71.0,Central nervous system,Low-grade gliomas
383,5E2539E0-2088-43DF-AD2A-F854D8BB6D30,Temodar,Chemotherapy,Dead,WITH TUMOR,Stable Disease,Stable Disease,466,MALE,71,C71.0,Central nervous system,Low-grade gliomas
384,FC3948FB-DF27-4149-BBFB-04443DFECC19,I 131 81C6,Immunotherapy,Dead,WITH TUMOR,,,23,MALE,42,C71.0,Central nervous system,Low-grade gliomas
385,23C335F6-5749-4443-8AE8-61CCCBB137CB,Temodar,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,Low-grade gliomas
386,23C335F6-5749-4443-8AE8-61CCCBB137CB,Temodar,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,Low-grade gliomas
387,23C335F6-5749-4443-8AE8-61CCCBB137CB,Avastin,Immunotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,Low-grade gliomas
388,23C335F6-5749-4443-8AE8-61CCCBB137CB,Avastin,Immunotherapy,Dead,WITH TUMOR,Progressive Disease,Stable Disease,987,FEMALE,26,C71.0,Central nervous system,Low-grade gliomas
389,23C335F6-5749-4443-8AE8-61CCCBB137CB,Gleevec,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Stable Disease,987,FEMALE,26,C71.0,Central nervous system,Low-grade gliomas
390,23C335F6-5749-4443-8AE8-61CCCBB137CB,Gleevec,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,Low-grade gliomas
391,23C335F6-5749-4443-8AE8-61CCCBB137CB,Avastin,Immunotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,Low-grade gliomas
392,23C335F6-5749-4443-8AE8-61CCCBB137CB,Gleevec,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,Low-grade gliomas
393,23C335F6-5749-4443-8AE8-61CCCBB137CB,Avastin,Immunotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,Low-grade gliomas
394,23C335F6-5749-4443-8AE8-61CCCBB137CB,CPT-11,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,987,FEMALE,26,C71.0,Central nervous system,Low-grade gliomas
395,5EEF573E-6A44-4DC7-8AA7-B136863CE910,CCNU,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,1120,MALE,28,C71.0,Central nervous system,Low-grade gliomas
396,5EEF573E-6A44-4DC7-8AA7-B136863CE910,Avastin,Immunotherapy,Dead,WITH TUMOR,Progressive Disease,Stable Disease,1120,MALE,28,C71.0,Central nervous system,Low-grade gliomas
397,5EEF573E-6A44-4DC7-8AA7-B136863CE910,CPT-11,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Stable Disease,1120,MALE,28,C71.0,Central nervous system,Low-grade gliomas
398,5EEF573E-6A44-4DC7-8AA7-B136863CE910,VP-16,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,1120,MALE,28,C71.0,Central nervous system,Low-grade gliomas
399,5EEF573E-6A44-4DC7-8AA7-B136863CE910,Temodar,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,1120,MALE,28,C71.0,Central nervous system,Low-grade gliomas
400,722C172F-46E6-47A1-82E5-3207278DF89B,Temodar,Chemotherapy,Dead,WITH TUMOR,Stable Disease,Stable Disease,4445,FEMALE,27,C71.0,Central nervous system,Low-grade gliomas
401,722C172F-46E6-47A1-82E5-3207278DF89B,Temodar,Chemotherapy,Dead,WITH TUMOR,Stable Disease,Clinical Progressive Disease,4445,FEMALE,27,C71.0,Central nervous system,Low-grade gliomas
402,722C172F-46E6-47A1-82E5-3207278DF89B,CCNU,Chemotherapy,Dead,WITH TUMOR,Stable Disease,Stable Disease,4445,FEMALE,27,C71.0,Central nervous system,Low-grade gliomas
403,722C172F-46E6-47A1-82E5-3207278DF89B,Temodar,Chemotherapy,Dead,WITH TUMOR,Stable Disease,Clinical Progressive Disease,4445,FEMALE,27,C71.0,Central nervous system,Low-grade gliomas
404,722C172F-46E6-47A1-82E5-3207278DF89B,VP-16,Chemotherapy,Dead,WITH TUMOR,Stable Disease,Clinical Progressive Disease,4445,FEMALE,27,C71.0,Central nervous system,Low-grade gliomas
405,722C172F-46E6-47A1-82E5-3207278DF89B,Avastin,Immunotherapy,Dead,WITH TUMOR,Stable Disease,,4445,FEMALE,27,C71.0,Central nervous system,Low-grade gliomas
406,97FFBE14-9070-4A5A-8760-225A88834B40,Temodar,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,398,FEMALE,58,C71.0,Central nervous system,Low-grade gliomas
407,97FFBE14-9070-4A5A-8760-225A88834B40,Temodar,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,398,FEMALE,58,C71.0,Central nervous system,Low-grade gliomas
408,97FFBE14-9070-4A5A-8760-225A88834B40,Temodar,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Stable Disease,398,FEMALE,58,C71.0,Central nervous system,Low-grade gliomas
409,97FFBE14-9070-4A5A-8760-225A88834B40,Avastin,Immunotherapy,Dead,WITH TUMOR,Progressive Disease,Stable Disease,398,FEMALE,58,C71.0,Central nervous system,Low-grade gliomas
410,97FFBE14-9070-4A5A-8760-225A88834B40,Temodar,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Stable Disease,398,FEMALE,58,C71.0,Central nervous system,Low-grade gliomas
411,97FFBE14-9070-4A5A-8760-225A88834B40,Avastin,Immunotherapy,Dead,WITH TUMOR,Progressive Disease,Stable Disease,398,FEMALE,58,C71.0,Central nervous system,Low-grade gliomas
412,3AC41CC6-5DFB-40A1-BD13-5DC7CA2BB6F3,I131-81C6,Immunotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,2235,FEMALE,31,C71.0,Central nervous system,Low-grade gliomas
413,3AC41CC6-5DFB-40A1-BD13-5DC7CA2BB6F3,CCNU,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,2235,FEMALE,31,C71.0,Central nervous system,Low-grade gliomas
414,3AC41CC6-5DFB-40A1-BD13-5DC7CA2BB6F3,Procarbazine,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,2235,FEMALE,31,C71.0,Central nervous system,Low-grade gliomas
415,3AC41CC6-5DFB-40A1-BD13-5DC7CA2BB6F3,Vincristine,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,2235,FEMALE,31,C71.0,Central nervous system,Low-grade gliomas
416,3AC41CC6-5DFB-40A1-BD13-5DC7CA2BB6F3,CPT-11,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,2235,FEMALE,31,C71.0,Central nervous system,Low-grade gliomas
417,975E17C2-B93C-4D45-8A85-786F365E4A93,Gliadel,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Stable Disease,4412,MALE,35,C71.0,Central nervous system,Low-grade gliomas
418,975E17C2-B93C-4D45-8A85-786F365E4A93,Temodar,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,4412,MALE,35,C71.0,Central nervous system,Low-grade gliomas
419,975E17C2-B93C-4D45-8A85-786F365E4A93,CCNU,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,4412,MALE,35,C71.0,Central nervous system,Low-grade gliomas
420,975E17C2-B93C-4D45-8A85-786F365E4A93,Thalidomide,,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,4412,MALE,35,C71.0,Central nervous system,Low-grade gliomas
421,975E17C2-B93C-4D45-8A85-786F365E4A93,Cyclophosphamide,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,4412,MALE,35,C71.0,Central nervous system,Low-grade gliomas
422,975E17C2-B93C-4D45-8A85-786F365E4A93,Karenitecin,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,4412,MALE,35,C71.0,Central nervous system,Low-grade gliomas
423,975E17C2-B93C-4D45-8A85-786F365E4A93,Temodar,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Stable Disease,4412,MALE,35,C71.0,Central nervous system,Low-grade gliomas
424,975E17C2-B93C-4D45-8A85-786F365E4A93,Tamoxifen,Hormone Therapy,Dead,WITH TUMOR,Progressive Disease,Stable Disease,4412,MALE,35,C71.0,Central nervous system,Low-grade gliomas
425,975E17C2-B93C-4D45-8A85-786F365E4A93,Avastin,Immunotherapy,Dead,WITH TUMOR,Progressive Disease,Stable Disease,4412,MALE,35,C71.0,Central nervous system,Low-grade gliomas
426,975E17C2-B93C-4D45-8A85-786F365E4A93,Avastin,Immunotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,4412,MALE,35,C71.0,Central nervous system,Low-grade gliomas
427,975E17C2-B93C-4D45-8A85-786F365E4A93,Temodar,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,4412,MALE,35,C71.0,Central nervous system,Low-grade gliomas
428,975E17C2-B93C-4D45-8A85-786F365E4A93,Avastin,Immunotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,4412,MALE,35,C71.0,Central nervous system,Low-grade gliomas
429,975E17C2-B93C-4D45-8A85-786F365E4A93,Carboplatin,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,4412,MALE,35,C71.0,Central nervous system,Low-grade gliomas
430,8B10F00F-FDE6-423D-BC36-027931359A5A,Temodar,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Stable Disease,984,FEMALE,41,C71.0,Central nervous system,Low-grade gliomas
431,8B10F00F-FDE6-423D-BC36-027931359A5A,Temodar,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,984,FEMALE,41,C71.0,Central nervous system,Low-grade gliomas
432,8B10F00F-FDE6-423D-BC36-027931359A5A,Avastin,Immunotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,984,FEMALE,41,C71.0,Central nervous system,Low-grade gliomas
433,e09f93e1-1649-48fa-9e2e-d13ac6d50b97,Temodar,Chemotherapy,Alive,WITH TUMOR,,,,MALE,54,C71.0,Central nervous system,Low-grade gliomas
434,e09f93e1-1649-48fa-9e2e-d13ac6d50b97,Temodar,Chemotherapy,Alive,WITH TUMOR,,,,MALE,54,C71.0,Central nervous system,Low-grade gliomas
435,68f550ca-3a33-45e4-b1c9-14f99e543263,Temodar,Chemotherapy,Alive,WITH TUMOR,,,,MALE,23,C71.0,Central nervous system,Low-grade gliomas
436,68f550ca-3a33-45e4-b1c9-14f99e543263,Temodar,Chemotherapy,Alive,WITH TUMOR,,Clinical Progressive Disease,,MALE,23,C71.0,Central nervous system,Low-grade gliomas
437,68f550ca-3a33-45e4-b1c9-14f99e543263,Avastin,Chemotherapy,Alive,WITH TUMOR,,Clinical Progressive Disease,,MALE,23,C71.0,Central nervous system,Low-grade gliomas
438,68f550ca-3a33-45e4-b1c9-14f99e543263,BCNU,Chemotherapy,Alive,WITH TUMOR,,Clinical Progressive Disease,,MALE,23,C71.0,Central nervous system,Low-grade gliomas
439,2cfc07f3-a31c-41a2-a9e3-b708d2421a78,Temodar,Chemotherapy,Alive,WITH TUMOR,,,,FEMALE,39,C71.0,Central nervous system,Low-grade gliomas
440,dadd7428-9e4d-4652-9469-ab521b88d529,Temodar,Chemotherapy,Alive,WITH TUMOR,,,,FEMALE,59,C71.0,Central nervous system,Low-grade gliomas
441,dadd7428-9e4d-4652-9469-ab521b88d529,Avastin,Chemotherapy,Alive,WITH TUMOR,,Stable Disease,,FEMALE,59,C71.0,Central nervous system,Low-grade gliomas
442,8d07b1e8-5d1d-4a43-b616-d29dd58ce5fe,Temodar,Chemotherapy,Alive,WITH TUMOR,,Stable Disease,,MALE,30,C71.0,Central nervous system,Low-grade gliomas
443,e4d9b696-3311-44e7-9191-fde56c080a00,Temodar,Chemotherapy,Alive,TUMOR FREE,,,,FEMALE,23,C71.0,Central nervous system,Low-grade gliomas
444,5f10cd91-1e03-4016-b35a-8629a1a8fcc9,Temodar,Chemotherapy,Alive,WITH TUMOR,,,,MALE,63,C71.0,Central nervous system,Low-grade gliomas
445,b342e980-8383-4f1b-bf57-4098c37a536c,Temodar,Chemotherapy,Alive,TUMOR FREE,,,,MALE,48,C71.0,Central nervous system,Low-grade gliomas
446,1f54d21e-752f-496d-8453-4b9b8738cbce,Temodar,Chemotherapy,Alive,TUMOR FREE,,,,FEMALE,31,C71.0,Central nervous system,Low-grade gliomas
447,1f54d21e-752f-496d-8453-4b9b8738cbce,Temodar,Chemotherapy,Alive,TUMOR FREE,,Stable Disease,,FEMALE,31,C71.0,Central nervous system,Low-grade gliomas
448,1f54d21e-752f-496d-8453-4b9b8738cbce,Temodar,Chemotherapy,Alive,TUMOR FREE,,Stable Disease,,FEMALE,31,C71.0,Central nervous system,Low-grade gliomas
449,1159c88c-39d0-4c03-9c66-36af5340a67a,Temodar,Chemotherapy,Alive,WITH TUMOR,,Stable Disease,,MALE,23,C71.0,Central nervous system,Low-grade gliomas
450,fb3884df-3680-4c5b-8092-981007aeba03,Temodar,Chemotherapy,Alive,TUMOR FREE,,Stable Disease,,MALE,37,C71.0,Central nervous system,Low-grade gliomas
451,fb3884df-3680-4c5b-8092-981007aeba03,Temodar,Chemotherapy,Alive,TUMOR FREE,,Complete Response,,MALE,37,C71.0,Central nervous system,Low-grade gliomas
452,5469c0e8-0c58-4870-b897-8fa0704599a7,Temodar,Chemotherapy,Alive,WITH TUMOR,Stable Disease,Stable Disease,,FEMALE,33,C71.0,Central nervous system,Low-grade gliomas
453,5469c0e8-0c58-4870-b897-8fa0704599a7,Temodar,Chemotherapy,Alive,WITH TUMOR,Stable Disease,Stable Disease,,FEMALE,33,C71.0,Central nervous system,Low-grade gliomas
454,029b33b1-7ea9-4b77-a615-7eb0e3ebd5e7,Temodar,Chemotherapy,Alive,WITH TUMOR,,Stable Disease,,MALE,30,C71.0,Central nervous system,Low-grade gliomas
455,029b33b1-7ea9-4b77-a615-7eb0e3ebd5e7,Temodar,Chemotherapy,Alive,WITH TUMOR,,Stable Disease,,MALE,30,C71.0,Central nervous system,Low-grade gliomas
456,DCE168B1-D2A9-4409-8437-AB382F6D7D31,Temodar,Chemotherapy,Alive,TUMOR FREE,,Stable Disease,,MALE,63,C71.1,Central nervous system,Low-grade gliomas
457,DCE168B1-D2A9-4409-8437-AB382F6D7D31,Temodar,Chemotherapy,Alive,TUMOR FREE,,Stable Disease,,MALE,63,C71.1,Central nervous system,Low-grade gliomas
458,DCE168B1-D2A9-4409-8437-AB382F6D7D31,Avastin,,Alive,TUMOR FREE,,Clinical Progressive Disease,,MALE,63,C71.1,Central nervous system,Low-grade gliomas
459,AE4F0714-3B74-46C0-9C1B-F028C7CF2E62,Temodar,Chemotherapy,Alive,WITH TUMOR,Progressive Disease,Stable Disease,,FEMALE,52,C71.0,Central nervous system,Low-grade gliomas
460,AE4F0714-3B74-46C0-9C1B-F028C7CF2E62,Temodar,Chemotherapy,Alive,WITH TUMOR,Progressive Disease,,,FEMALE,52,C71.0,Central nervous system,Low-grade gliomas
461,C6CEB220-282E-4EEF-8D36-4CE0A625CF7E,Temodar,Chemotherapy,Alive,WITH TUMOR,Complete Remission/Response,Stable Disease,,FEMALE,20,C71.0,Central nervous system,Low-grade gliomas
462,98E82E98-341A-4BCA-92C0-23C65C1BF94F,Temodar,Chemotherapy,Alive,WITH TUMOR,,,,FEMALE,53,C71.0,Central nervous system,Low-grade gliomas
463,5B199E7E-CC23-4065-88AD-FDFE3D0683D6,Temodar,Chemotherapy,Alive,WITH TUMOR,Stable Disease,Stable Disease,,FEMALE,50,C71.0,Central nervous system,Low-grade gliomas
464,1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Temodar,Chemotherapy,Alive,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,,FEMALE,33,C71.0,Central nervous system,Low-grade gliomas
465,1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Temodar,Chemotherapy,Alive,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,,FEMALE,33,C71.0,Central nervous system,Low-grade gliomas
466,1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Avastin,Immunotherapy,Alive,WITH TUMOR,Progressive Disease,,,FEMALE,33,C71.0,Central nervous system,Low-grade gliomas
467,1F5B6B07-45F5-4DA4-932A-DF9665F6C538,CCNU,Chemotherapy,Alive,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,,FEMALE,33,C71.0,Central nervous system,Low-grade gliomas
468,1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Hydroxyurea,Chemotherapy,Alive,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,,FEMALE,33,C71.0,Central nervous system,Low-grade gliomas
469,1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Imatinib,Chemotherapy,Alive,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,,FEMALE,33,C71.0,Central nervous system,Low-grade gliomas
470,1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Carboplatin 5 AUC,Chemotherapy,Alive,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,,FEMALE,33,C71.0,Central nervous system,Low-grade gliomas
471,1F5B6B07-45F5-4DA4-932A-DF9665F6C538,Etoposide,Chemotherapy,Alive,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,,FEMALE,33,C71.0,Central nervous system,Low-grade gliomas
472,872A12B4-8CBD-49D2-AC98-D846587F5794,Temodar,Chemotherapy,Alive,WITH TUMOR,Stable Disease,,,FEMALE,37,C71.0,Central nervous system,Low-grade gliomas
473,7E17E6FD-ED83-471F-91E3-5934885C8E87,Temodar,Chemotherapy,Alive,TUMOR FREE,Complete Remission/Response,,,FEMALE,61,C71.0,Central nervous system,Low-grade gliomas
474,5b9d7565-a933-449d-8ffa-ec5f82db2e77,Temozolomide,Chemotherapy,Alive,,,Complete Response,,MALE,25,C71.0,Central nervous system,Low-grade gliomas
475,e6c55ba6-4c8a-4ea4-8dde-74d01915db02,temodar,Chemotherapy,Alive,TUMOR FREE,,,,MALE,30,C71.0,Central nervous system,Low-grade gliomas
476,b9e2f4d1-866c-4c62-a9c8-8de7eb364a6e,Temodar,Chemotherapy,Alive,WITH TUMOR,,,,MALE,30,C71.0,Central nervous system,Low-grade gliomas
477,b9e2f4d1-866c-4c62-a9c8-8de7eb364a6e,Temodar,Chemotherapy,Alive,WITH TUMOR,,,,MALE,30,C71.0,Central nervous system,Low-grade gliomas
478,fee2114e-f723-4374-91f8-f1dcc6b3eaee,Temodar,Chemotherapy,Alive,TUMOR FREE,,,,MALE,37,C71.9,Central nervous system,Low-grade gliomas
479,41456932-436e-4cdb-bfe8-97d089656786,Temodar,Chemotherapy,Alive,TUMOR FREE,,,,MALE,67,C71.9,Central nervous system,Low-grade gliomas
480,41456932-436e-4cdb-bfe8-97d089656786,Temodar,Chemotherapy,Alive,TUMOR FREE,,,,MALE,67,C71.9,Central nervous system,Low-grade gliomas
481,41456932-436e-4cdb-bfe8-97d089656786,Temodar,Chemotherapy,Alive,TUMOR FREE,,,,MALE,67,C71.9,Central nervous system,Low-grade gliomas
482,27d0d3cb-16c0-4ba8-9662-95917f665004,temodar,Chemotherapy,Alive,TUMOR FREE,,,,MALE,26,C71.0,Central nervous system,Low-grade gliomas
483,27d0d3cb-16c0-4ba8-9662-95917f665004,temodar,Chemotherapy,Alive,TUMOR FREE,,,,MALE,26,C71.0,Central nervous system,Low-grade gliomas
484,38f4b9f3-6709-40ff-9a81-5fa2111b1ce6,Temodar,Chemotherapy,Alive,TUMOR FREE,Complete Remission/Response,Complete Response,,MALE,62,C71.0,Central nervous system,Low-grade gliomas
485,a96fabfa-e830-476a-b2a1-899689570bd9,Temodar,Chemotherapy,Alive,TUMOR FREE,,,,MALE,44,C71.9,Central nervous system,Low-grade gliomas
486,a96fabfa-e830-476a-b2a1-899689570bd9,Temodar,Chemotherapy,Alive,TUMOR FREE,,,,MALE,44,C71.9,Central nervous system,Low-grade gliomas
487,325138ab-2947-4131-b40e-971f024723cc,Avastin,Targeted Molecular therapy,Alive,WITH TUMOR,,,,MALE,33,C71.9,Central nervous system,Low-grade gliomas
488,325138ab-2947-4131-b40e-971f024723cc,Temodar,Chemotherapy,Alive,WITH TUMOR,,,,MALE,33,C71.9,Central nervous system,Low-grade gliomas
489,325138ab-2947-4131-b40e-971f024723cc,Temodar,Chemotherapy,Alive,WITH TUMOR,,,,MALE,33,C71.9,Central nervous system,Low-grade gliomas
490,448d3e3b-622c-4e79-bb1d-b5f2e92970e8,Temodar,Chemotherapy,Alive,WITH TUMOR,,,,FEMALE,18,C71.9,Central nervous system,Low-grade gliomas
491,183dd089-e932-4be2-b252-0e8572e7da4e,Temodar,Chemotherapy,Alive,TUMOR FREE,,Complete Response,,MALE,14,C71.0,Central nervous system,Low-grade gliomas
492,e7fdf164-a85d-4ff5-9676-d2215ca35403,Temodar,Chemotherapy,Alive,,,,,FEMALE,30,C71.9,Central nervous system,Low-grade gliomas
493,e7fdf164-a85d-4ff5-9676-d2215ca35403,Temodar,Chemotherapy,Alive,,,,,FEMALE,30,C71.9,Central nervous system,Low-grade gliomas
494,e7fdf164-a85d-4ff5-9676-d2215ca35403,Temodar,Chemotherapy,Alive,,,,,FEMALE,30,C71.9,Central nervous system,Low-grade gliomas
495,019c5de9-74fd-48b7-95a3-227532e16c5a,Temodar,Chemotherapy,Alive,TUMOR FREE,,Partial Response,,MALE,50,C71.0,Central nervous system,Low-grade gliomas
496,ffcec8e5-9fd3-4b42-a7cb-74761f713cf4,temodar,Chemotherapy,Alive,,,,,FEMALE,30,C71.9,Central nervous system,Low-grade gliomas
497,ffcec8e5-9fd3-4b42-a7cb-74761f713cf4,temodar,Chemotherapy,Alive,,,,,FEMALE,30,C71.9,Central nervous system,Low-grade gliomas
498,ffcec8e5-9fd3-4b42-a7cb-74761f713cf4,temodar,Chemotherapy,Alive,,,,,FEMALE,30,C71.9,Central nervous system,Low-grade gliomas
499,bfbc0d1e-2a0b-4c60-8a37-91e3ce4b79ee,temodar,Chemotherapy,Alive,TUMOR FREE,,,,MALE,34,C71.0,Central nervous system,Low-grade gliomas
500,bfbc0d1e-2a0b-4c60-8a37-91e3ce4b79ee,Temodar,Chemotherapy,Alive,TUMOR FREE,,,,MALE,34,C71.0,Central nervous system,Low-grade gliomas
501,0d61bdbd-24b1-4885-a099-9e42ca7eedcd,Temodar,Chemotherapy,Alive,TUMOR FREE,,,,MALE,40,C71.9,Central nervous system,Low-grade gliomas
502,0d61bdbd-24b1-4885-a099-9e42ca7eedcd,Irinotecan,Chemotherapy,Alive,TUMOR FREE,,,,MALE,40,C71.9,Central nervous system,Low-grade gliomas
503,0d61bdbd-24b1-4885-a099-9e42ca7eedcd,Temodar,Chemotherapy,Alive,TUMOR FREE,,,,MALE,40,C71.9,Central nervous system,Low-grade gliomas
504,0d61bdbd-24b1-4885-a099-9e42ca7eedcd,Avastin,Chemotherapy,Alive,TUMOR FREE,,,,MALE,40,C71.9,Central nervous system,Low-grade gliomas
505,00b18ad6-ff70-41fe-8f4d-0763ac8f28b9,temodar,Chemotherapy,Alive,,,,,MALE,53,C71.0,Central nervous system,Low-grade gliomas
506,00b18ad6-ff70-41fe-8f4d-0763ac8f28b9,temodar,Chemotherapy,Alive,,,,,MALE,53,C71.0,Central nervous system,Low-grade gliomas
507,3d58ded1-b7cf-420c-ba59-5b424683f0df,Temodar,Chemotherapy,Alive,TUMOR FREE,,,,FEMALE,29,C71.0,Central nervous system,Low-grade gliomas
508,3d58ded1-b7cf-420c-ba59-5b424683f0df,Temodar,Chemotherapy,Alive,TUMOR FREE,,,,FEMALE,29,C71.0,Central nervous system,Low-grade gliomas
509,7740824e-905f-47a0-b235-54561ef58ba3,Temodar,Chemotherapy,Alive,TUMOR FREE,,,,MALE,59,C71.0,Central nervous system,Low-grade gliomas
510,7740824e-905f-47a0-b235-54561ef58ba3,Temodar,Chemotherapy,Alive,TUMOR FREE,,,,MALE,59,C71.0,Central nervous system,Low-grade gliomas
511,7740824e-905f-47a0-b235-54561ef58ba3,Temodar,Chemotherapy,Alive,TUMOR FREE,,,,MALE,59,C71.0,Central nervous system,Low-grade gliomas
512,d58b535a-6c95-43bb-ad88-0600e6447537,Temodar,Chemotherapy,Alive,TUMOR FREE,,,,FEMALE,58,C71.0,Central nervous system,Low-grade gliomas
513,d58b535a-6c95-43bb-ad88-0600e6447537,Temodar,Chemotherapy,Alive,TUMOR FREE,,,,FEMALE,58,C71.0,Central nervous system,Low-grade gliomas
514,491ea65b-86c8-4686-99cf-f09505e20183,Temodar,Chemotherapy,Alive,,,,,FEMALE,51,C71.0,Central nervous system,Low-grade gliomas
515,491ea65b-86c8-4686-99cf-f09505e20183,Temodar,Chemotherapy,Alive,,,,,FEMALE,51,C71.0,Central nervous system,Low-grade gliomas
516,5017c115-39b8-4c5c-8be6-2cb298d7c641,Temodar,Chemotherapy,Alive,,,,,FEMALE,29,C71.0,Central nervous system,Low-grade gliomas
517,40343ebd-0d62-401e-83a4-6cdb57662ec0,Temodar,Chemotherapy,Alive,TUMOR FREE,,,,MALE,39,C71.0,Central nervous system,Low-grade gliomas
518,40343ebd-0d62-401e-83a4-6cdb57662ec0,Temodar,Chemotherapy,Alive,TUMOR FREE,,,,MALE,39,C71.0,Central nervous system,Low-grade gliomas
519,c2c16878-b615-496c-8fcb-d49c97e15551,Temodar,Chemotherapy,Alive,TUMOR FREE,,,,MALE,35,C71.0,Central nervous system,Low-grade gliomas
520,775c04e6-a02d-44a4-86f7-496056edd249,Temodar,Chemotherapy,Alive,TUMOR FREE,,,,FEMALE,41,C71.0,Central nervous system,Low-grade gliomas
521,775c04e6-a02d-44a4-86f7-496056edd249,Temodar,Chemotherapy,Alive,TUMOR FREE,,,,FEMALE,41,C71.0,Central nervous system,Low-grade gliomas
522,775c04e6-a02d-44a4-86f7-496056edd249,Temodar,Chemotherapy,Alive,TUMOR FREE,,,,FEMALE,41,C71.0,Central nervous system,Low-grade gliomas
523,c916b9a4-008e-4d79-a50c-f15c3549fcf6,Temodar,Chemotherapy,Alive,TUMOR FREE,,,,MALE,31,C71.0,Central nervous system,Low-grade gliomas
524,c916b9a4-008e-4d79-a50c-f15c3549fcf6,Temodar,Chemotherapy,Alive,TUMOR FREE,,,,MALE,31,C71.0,Central nervous system,Low-grade gliomas
525,86aa5790-9afd-4653-926a-625516df1f56,Temodar,Chemotherapy,Alive,,Stable Disease,Stable Disease,,FEMALE,44,C71.0,Central nervous system,Low-grade gliomas
526,86aa5790-9afd-4653-926a-625516df1f56,Temodar,Chemotherapy,Alive,,Stable Disease,,,FEMALE,44,C71.0,Central nervous system,Low-grade gliomas
527,58de25d5-8a32-4412-866b-acac2e321bfa,Temodar,Chemotherapy,Alive,,,Stable Disease,,MALE,55,C71.0,Central nervous system,Low-grade gliomas
528,58de25d5-8a32-4412-866b-acac2e321bfa,temodar,Chemotherapy,Alive,,,Clinical Progressive Disease,,MALE,55,C71.0,Central nervous system,Low-grade gliomas
529,e669a4b7-a494-490a-b78c-e664c59d0697,Temodar,Chemotherapy,Dead,WITH TUMOR,,Clinical Progressive Disease,1933,FEMALE,37,C71.0,Central nervous system,Low-grade gliomas
530,e669a4b7-a494-490a-b78c-e664c59d0697,Avastin,Targeted Molecular therapy,Dead,WITH TUMOR,,Clinical Progressive Disease,1933,FEMALE,37,C71.0,Central nervous system,Low-grade gliomas
531,9e621541-d603-4d2d-b86e-2834d3b9f9a5,temodar,Chemotherapy,Alive,TUMOR FREE,,Partial Response,,FEMALE,49,C71.0,Central nervous system,Low-grade gliomas
532,9e621541-d603-4d2d-b86e-2834d3b9f9a5,temodar,Chemotherapy,Alive,TUMOR FREE,,Complete Response,,FEMALE,49,C71.0,Central nervous system,Low-grade gliomas
533,0906ddde-02fa-417d-927b-1c400b189cac,Temodar,Chemotherapy,Alive,TUMOR FREE,,Complete Response,,MALE,36,C71.0,Central nervous system,Low-grade gliomas
534,f625e522-226b-450f-af94-dd2f5adb605e,Temodar,Chemotherapy,Alive,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,,MALE,47,C71.0,Central nervous system,Low-grade gliomas
535,f625e522-226b-450f-af94-dd2f5adb605e,Avastin,Targeted Molecular therapy,Alive,WITH TUMOR,Progressive Disease,Complete Response,,MALE,47,C71.0,Central nervous system,Low-grade gliomas
536,f625e522-226b-450f-af94-dd2f5adb605e,CeeNU,Chemotherapy,Alive,WITH TUMOR,Progressive Disease,,,MALE,47,C71.0,Central nervous system,Low-grade gliomas
537,274496D6-0A9B-45CA-876F-B91F7277963C,Temodar,Chemotherapy,Alive,TUMOR FREE,Complete Remission/Response,Complete Response,,FEMALE,51,C71.0,Central nervous system,Low-grade gliomas
538,274496D6-0A9B-45CA-876F-B91F7277963C,Temodar,Chemotherapy,Alive,TUMOR FREE,Complete Remission/Response,Partial Response,,FEMALE,51,C71.0,Central nervous system,Low-grade gliomas
539,7E41BABA-7EF6-4030-B595-D95CD96336B5,Temodar,Chemotherapy,Alive,TUMOR FREE,Complete Remission/Response,,,FEMALE,33,C71.0,Central nervous system,Low-grade gliomas
540,5A2D3BFA-4BDD-417D-9796-E3699760114C,Temodar,Chemotherapy,Alive,WITH TUMOR,Partial Remission/Response,Partial Response,,FEMALE,65,C71.0,Central nervous system,Low-grade gliomas
541,8655FA51-D784-4F8D-9BC8-F1DA7303D22F,Temodar,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,162,FEMALE,70,C71.0,Central nervous system,Low-grade gliomas
542,A4E2E507-7DDF-43DF-B959-FE451971AF1E,Temodar,Chemotherapy,Alive,,,,,FEMALE,37,C71.0,Central nervous system,Low-grade gliomas
543,C13BAC88-C85B-4EE3-A51C-FD503CD7E726,Temodar,Chemotherapy,Alive,TUMOR FREE,Complete Remission/Response,Complete Response,,FEMALE,51,C71.0,Central nervous system,Low-grade gliomas
544,EFFB5839-24A2-4B8C-8B6D-08CB66503D16,Temodar,Chemotherapy,Alive,TUMOR FREE,Complete Remission/Response,,,FEMALE,20,C71.0,Central nervous system,Low-grade gliomas
545,CF2A1B98-5693-4C04-9167-F85E69A88A4A,Temodar,Chemotherapy,Alive,TUMOR FREE,Complete Remission/Response,,,MALE,22,C71.0,Central nervous system,Low-grade gliomas
546,77396AE6-3838-47BF-AAAE-F9A0F401EC7F,Temodar,Chemotherapy,Alive,TUMOR FREE,Complete Remission/Response,Complete Response,,MALE,66,C71.0,Central nervous system,Low-grade gliomas
547,FDFF46A7-F92A-45CF-8756-6C73A406C923,Temodar,Chemotherapy,Alive,,Stable Disease,,,MALE,62,C71.0,Central nervous system,Low-grade gliomas
548,A3BE4E6F-C845-4D64-8111-D63FDF8CC8F1,temodar,Chemotherapy,Alive,TUMOR FREE,Complete Remission/Response,Complete Response,,FEMALE,58,C71.0,Central nervous system,Low-grade gliomas
549,55a67639-ed05-4143-af96-a377bc5489ee,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,,,MALE,37,C71.0,Central nervous system,Low-grade gliomas
550,42251e02-b687-4bf1-a1b6-e3dd978542e4,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,,,MALE,39,C71.0,Central nervous system,Low-grade gliomas
551,42251e02-b687-4bf1-a1b6-e3dd978542e4,Lomustine,Chemotherapy,Alive,WITH TUMOR,,Clinical Progressive Disease,,MALE,39,C71.0,Central nervous system,Low-grade gliomas
552,42251e02-b687-4bf1-a1b6-e3dd978542e4,Vincristine (sulfate),Chemotherapy,Alive,WITH TUMOR,,Clinical Progressive Disease,,MALE,39,C71.0,Central nervous system,Low-grade gliomas
553,42251e02-b687-4bf1-a1b6-e3dd978542e4,Procarbazine,Chemotherapy,Alive,WITH TUMOR,,Clinical Progressive Disease,,MALE,39,C71.0,Central nervous system,Low-grade gliomas
554,42251e02-b687-4bf1-a1b6-e3dd978542e4,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,Clinical Progressive Disease,,MALE,39,C71.0,Central nervous system,Low-grade gliomas
555,42251e02-b687-4bf1-a1b6-e3dd978542e4,Carboplatin,Chemotherapy,Alive,WITH TUMOR,,,,MALE,39,C71.0,Central nervous system,Low-grade gliomas
556,42251e02-b687-4bf1-a1b6-e3dd978542e4,Bevacizumab,Chemotherapy,Alive,WITH TUMOR,,,,MALE,39,C71.0,Central nervous system,Low-grade gliomas
557,a85fdb41-24c1-420d-8905-ec297f018bd9,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,,,MALE,35,C71.0,Central nervous system,Low-grade gliomas
558,bc3b4816-df1d-44ed-a8c6-f32c8e011a1f,Temozolomide,Chemotherapy,Alive,WITH TUMOR,Partial Remission/Response,Stable Disease,,FEMALE,34,C71.0,Central nervous system,Low-grade gliomas
559,bc3b4816-df1d-44ed-a8c6-f32c8e011a1f,Temozolomide,Chemotherapy,Alive,WITH TUMOR,Partial Remission/Response,,,FEMALE,34,C71.0,Central nervous system,Low-grade gliomas
560,bc3b4816-df1d-44ed-a8c6-f32c8e011a1f,Temozolomide,Chemotherapy,Alive,WITH TUMOR,Partial Remission/Response,Partial Response,,FEMALE,34,C71.0,Central nervous system,Low-grade gliomas
561,bc3b4816-df1d-44ed-a8c6-f32c8e011a1f,Bevacizumab,Chemotherapy,Alive,WITH TUMOR,Partial Remission/Response,Partial Response,,FEMALE,34,C71.0,Central nervous system,Low-grade gliomas
562,bc3b4816-df1d-44ed-a8c6-f32c8e011a1f,Lomustine,Chemotherapy,Alive,WITH TUMOR,Partial Remission/Response,,,FEMALE,34,C71.0,Central nervous system,Low-grade gliomas
563,e3ed0c19-6acc-4be1-aae2-73fe73cc9f24,Temozolomide,Chemotherapy,Alive,WITH TUMOR,Stable Disease,Stable Disease,,MALE,36,C71.0,Central nervous system,Low-grade gliomas
564,e3ed0c19-6acc-4be1-aae2-73fe73cc9f24,Temozolomide,Chemotherapy,Alive,WITH TUMOR,Stable Disease,,,MALE,36,C71.0,Central nervous system,Low-grade gliomas
565,36cf458b-3c8e-48e7-92ab-aea1c698e417,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,Stable Disease,,MALE,31,C71.0,Central nervous system,Low-grade gliomas
566,6105c037-90f1-42d9-ac38-6e2252999a64,Temozolomide,Chemotherapy,Alive,WITH TUMOR,Stable Disease,,,MALE,39,C71.0,Central nervous system,Low-grade gliomas
567,8996DC64-8C5E-4E07-8ED8-2EB11C03626B,Temozolomide,Chemotherapy,Alive,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,,MALE,68,C71.0,Central nervous system,Low-grade gliomas
568,8996DC64-8C5E-4E07-8ED8-2EB11C03626B,Temozolomide,,Alive,WITH TUMOR,Progressive Disease,Stable Disease,,MALE,68,C71.0,Central nervous system,Low-grade gliomas
569,8A94FF28-A74D-4FE2-B9C0-06C01F0A3FB6,Temozolomide,Chemotherapy,Alive,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,,MALE,64,C71.0,Central nervous system,Low-grade gliomas
570,8A94FF28-A74D-4FE2-B9C0-06C01F0A3FB6,Bevacizumab,Chemotherapy,Alive,WITH TUMOR,Progressive Disease,,,MALE,64,C71.0,Central nervous system,Low-grade gliomas
571,0639B753-4099-4CA4-ADB9-763069A614EF,Temozolomide,Chemotherapy,Alive,WITH TUMOR,Stable Disease,Stable Disease,,FEMALE,42,C71.0,Central nervous system,Low-grade gliomas
572,0639B753-4099-4CA4-ADB9-763069A614EF,Temozolomide,Chemotherapy,Alive,WITH TUMOR,Stable Disease,Stable Disease,,FEMALE,42,C71.0,Central nervous system,Low-grade gliomas
573,a5f851c5-6130-4ea1-9f86-be59331a92f7,Bevacizumab,Targeted Molecular therapy,Dead,WITH TUMOR,,,578,MALE,43,C71.0,Central nervous system,Low-grade gliomas
574,a5f851c5-6130-4ea1-9f86-be59331a92f7,Irinotecan,Chemotherapy,Dead,WITH TUMOR,,,578,MALE,43,C71.0,Central nervous system,Low-grade gliomas
575,a0b7c7c8-a6f2-41ba-9e61-9b7f8fbbbe1f,Temodar,Chemotherapy,Alive,TUMOR FREE,,,,MALE,62,C71.0,Central nervous system,Low-grade gliomas
576,a0b7c7c8-a6f2-41ba-9e61-9b7f8fbbbe1f,Temodar,Chemotherapy,Alive,TUMOR FREE,,Complete Response,,MALE,62,C71.0,Central nervous system,Low-grade gliomas
577,442DF188-B678-45BB-BD9D-7071ED8AAA5A,Temozolomide,Chemotherapy,Alive,WITH TUMOR,Stable Disease,Stable Disease,,MALE,26,C71.0,Central nervous system,Low-grade gliomas
578,77472095-030D-4679-921D-8E8E217956C5,Temozolomide,Chemotherapy,Alive,TUMOR FREE,Progressive Disease,Clinical Progressive Disease,,FEMALE,45,C71.0,Central nervous system,Low-grade gliomas
579,1F13065A-40F7-455D-B8EB-F9A128722EAC,Temozolomide,,Alive,WITH TUMOR,,Partial Response,,FEMALE,41,C71.0,Central nervous system,Low-grade gliomas
580,7EB5D055-E1C8-4B93-9205-A49A6E79DFD4,Lomustine,Chemotherapy,Alive,WITH TUMOR,,Partial Response,,MALE,33,C71.9,Central nervous system,Low-grade gliomas
581,7EB5D055-E1C8-4B93-9205-A49A6E79DFD4,Vincristine,Chemotherapy,Alive,WITH TUMOR,,Partial Response,,MALE,33,C71.9,Central nervous system,Low-grade gliomas
582,7EB5D055-E1C8-4B93-9205-A49A6E79DFD4,Procarbazine,Chemotherapy,Alive,WITH TUMOR,,Partial Response,,MALE,33,C71.9,Central nervous system,Low-grade gliomas
583,C85FA637-941A-4A9A-8029-F5B44F3DA430,Mustophoran,Chemotherapy,Alive,WITH TUMOR,,Partial Response,,FEMALE,36,C71.0,Central nervous system,Low-grade gliomas
584,C85FA637-941A-4A9A-8029-F5B44F3DA430,Avastin,,Alive,WITH TUMOR,,Partial Response,,FEMALE,36,C71.0,Central nervous system,Low-grade gliomas
585,C85FA637-941A-4A9A-8029-F5B44F3DA430,Themozolomide,,Alive,WITH TUMOR,,Partial Response,,FEMALE,36,C71.0,Central nervous system,Low-grade gliomas
586,0557B788-5AED-4919-85EB-A503AD893D75,Lomustine,Chemotherapy,Alive,,,Partial Response,,FEMALE,35,C71.0,Central nervous system,Low-grade gliomas
587,0557B788-5AED-4919-85EB-A503AD893D75,Vincristine,Chemotherapy,Alive,,,Partial Response,,FEMALE,35,C71.0,Central nervous system,Low-grade gliomas
588,0557B788-5AED-4919-85EB-A503AD893D75,Procarbazine,Chemotherapy,Alive,,,Partial Response,,FEMALE,35,C71.0,Central nervous system,Low-grade gliomas
589,141F0546-F6F2-408F-AC86-07CA4AADF3D0,Temozolomide,Chemotherapy,Alive,TUMOR FREE,Complete Remission/Response,,,FEMALE,64,C71.0,Central nervous system,Low-grade gliomas
590,D81B9957-8C82-4006-B111-449FA9FB95ED,Temozolomide,,Alive,TUMOR FREE,Complete Remission/Response,,,FEMALE,52,C71.0,Central nervous system,Low-grade gliomas
591,505E9812-D13E-42D3-AEE2-55A85D6F4551,TEMOZOLOMIDE,Chemotherapy,Alive,WITH TUMOR,Partial Remission/Response,Stable Disease,,FEMALE,38,C71.9,Central nervous system,Low-grade gliomas
592,AD72E61E-51E3-4992-AC77-65E895935736,PROCARBAZINE,Chemotherapy,Alive,WITH TUMOR,Stable Disease,Stable Disease,,FEMALE,43,C71.0,Central nervous system,Low-grade gliomas
593,AD72E61E-51E3-4992-AC77-65E895935736,LOMUSTINE,Chemotherapy,Alive,WITH TUMOR,Stable Disease,Stable Disease,,FEMALE,43,C71.0,Central nervous system,Low-grade gliomas
594,AD72E61E-51E3-4992-AC77-65E895935736,VINCRISTINE,Chemotherapy,Alive,WITH TUMOR,Stable Disease,Stable Disease,,FEMALE,43,C71.0,Central nervous system,Low-grade gliomas
595,451BAD4F-6D72-4526-9978-38E090FC479F,temozolomide,Chemotherapy,Alive,TUMOR FREE,Stable Disease,Stable Disease,,FEMALE,28,C71.0,Central nervous system,Low-grade gliomas
596,451BAD4F-6D72-4526-9978-38E090FC479F,lomustine,Chemotherapy,Alive,TUMOR FREE,Stable Disease,Stable Disease,,FEMALE,28,C71.0,Central nervous system,Low-grade gliomas
597,451BAD4F-6D72-4526-9978-38E090FC479F,vincristine,Chemotherapy,Alive,TUMOR FREE,Stable Disease,Stable Disease,,FEMALE,28,C71.0,Central nervous system,Low-grade gliomas
598,451BAD4F-6D72-4526-9978-38E090FC479F,Procarbazine,Chemotherapy,Alive,TUMOR FREE,Stable Disease,Stable Disease,,FEMALE,28,C71.0,Central nervous system,Low-grade gliomas
599,C2F9DFF7-751B-4704-8E6E-F4F800297030,VINCRISTINE,Chemotherapy,Alive,TUMOR FREE,,Stable Disease,,MALE,54,C71.0,Central nervous system,Low-grade gliomas
600,C2F9DFF7-751B-4704-8E6E-F4F800297030,LOMUSTINE,Chemotherapy,Alive,TUMOR FREE,,Stable Disease,,MALE,54,C71.0,Central nervous system,Low-grade gliomas
601,C2F9DFF7-751B-4704-8E6E-F4F800297030,procarbazine,Chemotherapy,Alive,TUMOR FREE,,Stable Disease,,MALE,54,C71.0,Central nervous system,Low-grade gliomas
602,6D17C327-435A-4CBA-9626-3B5B7B7375BB,TEMOZOLOMIDE,Chemotherapy,Alive,WITH TUMOR,Stable Disease,Stable Disease,,MALE,41,C71.0,Central nervous system,Low-grade gliomas
603,6D17C327-435A-4CBA-9626-3B5B7B7375BB,fotemustine,Chemotherapy,Alive,WITH TUMOR,Stable Disease,,,MALE,41,C71.0,Central nervous system,Low-grade gliomas
604,76CB16F9-37BE-450E-B60A-5F0D0F1EC2BC,Temozolomide,Chemotherapy,Alive,TUMOR FREE,,,,FEMALE,52,C71.0,Central nervous system,Low-grade gliomas
605,E1758D75-B2A0-4386-BD72-6B2421D4DA6B,Temozolomide,Chemotherapy,Alive,,,Stable Disease,,MALE,38,C71.0,Central nervous system,Low-grade gliomas
606,976D067B-9D7F-4920-A04D-E831EDC6C2C2,temozolomide,Chemotherapy,Alive,TUMOR FREE,Complete Remission/Response,Clinical Progressive Disease,,MALE,47,C71.0,Central nervous system,Low-grade gliomas
607,D209CFFC-FE21-4AE7-B610-E5668EA84A3B,temozolomide,Chemotherapy,Alive,WITH TUMOR,Stable Disease,Stable Disease,,FEMALE,56,C71.0,Central nervous system,Low-grade gliomas
608,62088274-A45B-4616-B086-B0DDD64895F0,temozolomide,Chemotherapy,Alive,TUMOR FREE,Complete Remission/Response,Clinical Progressive Disease,,MALE,48,C71.0,Central nervous system,Low-grade gliomas
609,62088274-A45B-4616-B086-B0DDD64895F0,lomustine,Chemotherapy,Alive,TUMOR FREE,Complete Remission/Response,,,MALE,48,C71.0,Central nervous system,Low-grade gliomas
610,62088274-A45B-4616-B086-B0DDD64895F0,Procarbazine,Chemotherapy,Alive,TUMOR FREE,Complete Remission/Response,,,MALE,48,C71.0,Central nervous system,Low-grade gliomas
611,62088274-A45B-4616-B086-B0DDD64895F0,Vincristine,Chemotherapy,Alive,TUMOR FREE,Complete Remission/Response,,,MALE,48,C71.0,Central nervous system,Low-grade gliomas
612,345D975C-E666-4614-81EB-5CCBB5BD2CF7,temozolomide,Chemotherapy,Alive,TUMOR FREE,Complete Remission/Response,,,FEMALE,38,C71.0,Central nervous system,Low-grade gliomas
613,41E4DC71-7767-44C2-9D38-110DCD37B451,Carmustine,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,1891,FEMALE,48,C71.0,Central nervous system,Low-grade gliomas
614,41E4DC71-7767-44C2-9D38-110DCD37B451,Temozolamide,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,1891,FEMALE,48,C71.0,Central nervous system,Low-grade gliomas
615,41E4DC71-7767-44C2-9D38-110DCD37B451,Bevacizumab,Targeted Molecular therapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,1891,FEMALE,48,C71.0,Central nervous system,Low-grade gliomas
616,048056CD-39DD-4134-A58B-70BEBB3DD2FF,Temozolamide,Chemotherapy,Alive,TUMOR FREE,Complete Remission/Response,Stable Disease,,MALE,50,C71.0,Central nervous system,Low-grade gliomas
617,C45E02E5-7E3C-4F36-8B8D-F54617E8A436,Temozolomide,Chemotherapy,Alive,WITH TUMOR,Partial Remission/Response,Stable Disease,,MALE,40,C71.0,Central nervous system,Low-grade gliomas
618,432FE4A9-2CDC-4323-AFF0-59E2FDEDA194,Temozolomide,Chemotherapy,Alive,WITH TUMOR,Complete Remission/Response,Complete Response,,MALE,46,C71.0,Central nervous system,Low-grade gliomas
619,DCBBACA6-A24B-4BED-95DE-314CFF71E436,Temozolomide,Chemotherapy,Alive,WITH TUMOR,Partial Remission/Response,Stable Disease,,MALE,50,C71.0,Central nervous system,Low-grade gliomas
620,A343FBE3-147A-4656-9E90-5408298CA12C,Temozolomide,Chemotherapy,Alive,WITH TUMOR,Partial Remission/Response,Stable Disease,,MALE,46,C71.0,Central nervous system,Low-grade gliomas
621,A343FBE3-147A-4656-9E90-5408298CA12C,Temozolomide,Chemotherapy,Alive,WITH TUMOR,Partial Remission/Response,Stable Disease,,MALE,46,C71.0,Central nervous system,Low-grade gliomas
622,A343FBE3-147A-4656-9E90-5408298CA12C,Bevacizumab,Targeted Molecular therapy,Alive,WITH TUMOR,Partial Remission/Response,,,MALE,46,C71.0,Central nervous system,Low-grade gliomas
623,A343FBE3-147A-4656-9E90-5408298CA12C,Carmustine,Chemotherapy,Alive,WITH TUMOR,Partial Remission/Response,Clinical Progressive Disease,,MALE,46,C71.0,Central nervous system,Low-grade gliomas
624,A343FBE3-147A-4656-9E90-5408298CA12C,Teniposide,Chemotherapy,Alive,WITH TUMOR,Partial Remission/Response,Clinical Progressive Disease,,MALE,46,C71.0,Central nervous system,Low-grade gliomas
625,A5E10E2E-5157-487B-88DC-6C70AD5E244A,Temozolomide,Chemotherapy,Alive,WITH TUMOR,Complete Remission/Response,Complete Response,,FEMALE,22,C71.0,Central nervous system,Low-grade gliomas
626,B10A9314-FD40-459E-97EA-AFFC636DCEEA,Bevacizumab,Targeted Molecular therapy,Alive,WITH TUMOR,Partial Remission/Response,,,MALE,24,C71.0,Central nervous system,Low-grade gliomas
627,B10A9314-FD40-459E-97EA-AFFC636DCEEA,Temozolomide,Chemotherapy,Alive,WITH TUMOR,Partial Remission/Response,Stable Disease,,MALE,24,C71.0,Central nervous system,Low-grade gliomas
628,B10A9314-FD40-459E-97EA-AFFC636DCEEA,Carmustin,Chemotherapy,Alive,WITH TUMOR,Partial Remission/Response,Clinical Progressive Disease,,MALE,24,C71.0,Central nervous system,Low-grade gliomas
629,B10A9314-FD40-459E-97EA-AFFC636DCEEA,Temozolomide,Chemotherapy,Alive,WITH TUMOR,Partial Remission/Response,Clinical Progressive Disease,,MALE,24,C71.0,Central nervous system,Low-grade gliomas
630,3E4851CA-4D69-4035-A2DD-8ED6E70F1FFB,Temozolomide,Chemotherapy,Alive,WITH TUMOR,Partial Remission/Response,Stable Disease,,MALE,58,C71.0,Central nervous system,Low-grade gliomas
631,6D2C49C3-0721-4BD2-B39F-7872F2DE996D,Temozolamide,Chemotherapy,Alive,WITH TUMOR,Partial Remission/Response,,,MALE,34,C71.0,Central nervous system,Low-grade gliomas
632,A1192DF3-7667-4D1E-A1A0-79F6CC827DCF,Temozolomide,Chemotherapy,Alive,WITH TUMOR,Progressive Disease,Stable Disease,,MALE,31,C71.0,Central nervous system,Low-grade gliomas
633,F79420CA-B0AE-417C-95F7-D28C35760202,Temozolomide,Chemotherapy,Alive,WITH TUMOR,Partial Remission/Response,Stable Disease,,FEMALE,59,C71.0,Central nervous system,Low-grade gliomas
634,F79420CA-B0AE-417C-95F7-D28C35760202,Bevacizumab,Targeted Molecular therapy,Alive,WITH TUMOR,Partial Remission/Response,,,FEMALE,59,C71.0,Central nervous system,Low-grade gliomas
635,A418FE65-DFDD-4C84-B27C-B4567B50F457,Temozolomide,Chemotherapy,Alive,WITH TUMOR,Progressive Disease,Stable Disease,,FEMALE,38,C71.0,Central nervous system,Low-grade gliomas
636,A418FE65-DFDD-4C84-B27C-B4567B50F457,Bevacizumab,Targeted Molecular therapy,Alive,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,,FEMALE,38,C71.0,Central nervous system,Low-grade gliomas
637,A418FE65-DFDD-4C84-B27C-B4567B50F457,Temozolomide,Chemotherapy,Alive,WITH TUMOR,Progressive Disease,,,FEMALE,38,C71.0,Central nervous system,Low-grade gliomas
638,A418FE65-DFDD-4C84-B27C-B4567B50F457,Lomustin,Chemotherapy,Alive,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,,FEMALE,38,C71.0,Central nervous system,Low-grade gliomas
639,A418FE65-DFDD-4C84-B27C-B4567B50F457,Pembrolizumab,Targeted Molecular therapy,Alive,WITH TUMOR,Progressive Disease,,,FEMALE,38,C71.0,Central nervous system,Low-grade gliomas
640,081B6532-0ED4-445A-BECB-CB2290F4854D,Temozolomide,Chemotherapy,Alive,WITH TUMOR,Partial Remission/Response,,,MALE,42,C71.0,Central nervous system,Low-grade gliomas
641,A80B0FAB-6189-497F-997F-77234B69179C,Temozolomide,Chemotherapy,Alive,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,,MALE,57,C71.0,Central nervous system,Low-grade gliomas
642,A80B0FAB-6189-497F-997F-77234B69179C,Temozolomide,Chemotherapy,Alive,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,,MALE,57,C71.0,Central nervous system,Low-grade gliomas
643,A80B0FAB-6189-497F-997F-77234B69179C,Bevacizumab,Targeted Molecular therapy,Alive,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,,MALE,57,C71.0,Central nervous system,Low-grade gliomas
644,A80B0FAB-6189-497F-997F-77234B69179C,Lomustine,Chemotherapy,Alive,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,,MALE,57,C71.0,Central nervous system,Low-grade gliomas
645,94B95C07-5F70-4A1B-B40F-DC13F6A160D5,Lomustine,Chemotherapy,Alive,WITH TUMOR,Partial Remission/Response,,,MALE,39,C71.0,Central nervous system,Low-grade gliomas
646,94B95C07-5F70-4A1B-B40F-DC13F6A160D5,Procarbazine,Chemotherapy,Alive,WITH TUMOR,Partial Remission/Response,,,MALE,39,C71.0,Central nervous system,Low-grade gliomas
647,94B95C07-5F70-4A1B-B40F-DC13F6A160D5,Vincristine,Chemotherapy,Alive,WITH TUMOR,Partial Remission/Response,,,MALE,39,C71.0,Central nervous system,Low-grade gliomas
648,01A13ABA-74A4-4895-A5AD-E5119925C202,Carmustine,Chemotherapy,Alive,WITH TUMOR,Partial Remission/Response,Stable Disease,,FEMALE,48,C71.0,Central nervous system,Low-grade gliomas
649,01A13ABA-74A4-4895-A5AD-E5119925C202,Teniposide,Chemotherapy,Alive,WITH TUMOR,Partial Remission/Response,Stable Disease,,FEMALE,48,C71.0,Central nervous system,Low-grade gliomas
650,6A8241A8-D9EE-414B-89FD-4C3B9F181CC7,Temozolomide,Chemotherapy,Alive,WITH TUMOR,Partial Remission/Response,Stable Disease,,FEMALE,30,C71.0,Central nervous system,Low-grade gliomas
651,6A8241A8-D9EE-414B-89FD-4C3B9F181CC7,Temozolomide,Chemotherapy,Alive,WITH TUMOR,Partial Remission/Response,,,FEMALE,30,C71.0,Central nervous system,Low-grade gliomas
652,6A8241A8-D9EE-414B-89FD-4C3B9F181CC7,Carmustine,Chemotherapy,Alive,WITH TUMOR,Partial Remission/Response,Clinical Progressive Disease,,FEMALE,30,C71.0,Central nervous system,Low-grade gliomas
653,6A8241A8-D9EE-414B-89FD-4C3B9F181CC7,Bevacizumab,Targeted Molecular therapy,Alive,WITH TUMOR,Partial Remission/Response,Clinical Progressive Disease,,FEMALE,30,C71.0,Central nervous system,Low-grade gliomas
654,6A8241A8-D9EE-414B-89FD-4C3B9F181CC7,Irinotecan,Chemotherapy,Alive,WITH TUMOR,Partial Remission/Response,Clinical Progressive Disease,,FEMALE,30,C71.0,Central nervous system,Low-grade gliomas
655,194E8231-E8D4-477F-8C62-E11F2484ECCE,Lomustine,Chemotherapy,Alive,WITH TUMOR,Partial Remission/Response,,,MALE,25,C71.0,Central nervous system,Low-grade gliomas
656,194E8231-E8D4-477F-8C62-E11F2484ECCE,Procarbazine,Chemotherapy,Alive,WITH TUMOR,Partial Remission/Response,,,MALE,25,C71.0,Central nervous system,Low-grade gliomas
657,194E8231-E8D4-477F-8C62-E11F2484ECCE,VINCRISTINE,Chemotherapy,Alive,WITH TUMOR,Partial Remission/Response,,,MALE,25,C71.0,Central nervous system,Low-grade gliomas
658,032096A6-1923-44B9-A1CB-181BED041C8E,Lomustine,Chemotherapy,Alive,WITH TUMOR,Partial Remission/Response,Stable Disease,,FEMALE,52,C71.0,Central nervous system,Low-grade gliomas
659,032096A6-1923-44B9-A1CB-181BED041C8E,Procarbazine,Chemotherapy,Alive,WITH TUMOR,Partial Remission/Response,Stable Disease,,FEMALE,52,C71.0,Central nervous system,Low-grade gliomas
660,032096A6-1923-44B9-A1CB-181BED041C8E,Vincristine,Chemotherapy,Alive,WITH TUMOR,Partial Remission/Response,Stable Disease,,FEMALE,52,C71.0,Central nervous system,Low-grade gliomas
661,765588AA-075F-477F-9C18-099D018D3A1B,Temozolomide,Chemotherapy,Alive,WITH TUMOR,Complete Remission/Response,Stable Disease,,FEMALE,54,C71.0,Central nervous system,Low-grade gliomas
662,427F4D23-2B76-4A2A-A498-0C3473F57169,Temozolomide,Chemotherapy,Alive,WITH TUMOR,Partial Remission/Response,,,FEMALE,36,C71.0,Central nervous system,Low-grade gliomas
663,94A2FF09-F7AC-4AEA-A2B2-0DC1B82AE635,Temozolomide,Chemotherapy,Alive,WITH TUMOR,Partial Remission/Response,Stable Disease,,FEMALE,35,C71.0,Central nervous system,Low-grade gliomas
664,78A212BC-A740-46BF-A10D-0B9809A5BB3F,Temozolamide,Chemotherapy,Alive,WITH TUMOR,Stable Disease,Stable Disease,,MALE,35,C71.0,Central nervous system,Low-grade gliomas
665,58650D08-7685-41DE-9AE0-21665F8F449F,Temozolomide,Chemotherapy,Alive,WITH TUMOR,Partial Remission/Response,Stable Disease,,MALE,46,C71.0,Central nervous system,Low-grade gliomas
666,A6975EB0-CFA6-4B7A-BBE4-72BBDD3D3B6F,Temozolomide,Chemotherapy,Alive,WITH TUMOR,Progressive Disease,Stable Disease,,MALE,27,C71.0,Central nervous system,Low-grade gliomas
667,A6975EB0-CFA6-4B7A-BBE4-72BBDD3D3B6F,Temozolamide,Chemotherapy,Alive,WITH TUMOR,Progressive Disease,Stable Disease,,MALE,27,C71.0,Central nervous system,Low-grade gliomas
668,A6975EB0-CFA6-4B7A-BBE4-72BBDD3D3B6F,Carmustine,Chemotherapy,Alive,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,,MALE,27,C71.0,Central nervous system,Low-grade gliomas
669,7883E417-A793-4614-9528-6C2E9E44379F,Temozolamide,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,961,FEMALE,44,C71.0,Central nervous system,Low-grade gliomas
670,7883E417-A793-4614-9528-6C2E9E44379F,Nimustine,Chemotherapy,Dead,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,961,FEMALE,44,C71.0,Central nervous system,Low-grade gliomas
671,C4F522C9-BFF5-4899-8D27-C105DAB795A9,Temozolomide,Chemotherapy,Alive,,Progressive Disease,Clinical Progressive Disease,,MALE,70,C71.0,Central nervous system,Low-grade gliomas
672,C4F522C9-BFF5-4899-8D27-C105DAB795A9,Temozolomide,Chemotherapy,Alive,,Progressive Disease,Clinical Progressive Disease,,MALE,70,C71.0,Central nervous system,Low-grade gliomas
673,CC8614C4-D535-4AD9-82F0-F4DC7AD11D0F,Temozolomide,Chemotherapy,Alive,WITH TUMOR,Partial Remission/Response,Stable Disease,,MALE,40,C71.0,Central nervous system,Low-grade gliomas
674,D13AC936-87A9-4164-BDAB-02CCF3908CFE,Temozolomide,Chemotherapy,Alive,WITH TUMOR,Complete Remission/Response,,,FEMALE,43,C71.0,Central nervous system,Low-grade gliomas
675,EE6BF12F-8A73-49E2-B566-368B2B42165B,Temozolomide,Chemotherapy,Alive,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,,MALE,40,C71.0,Central nervous system,Low-grade gliomas
676,8643437F-CD1B-47C8-86BD-87B6C2F80747,Temozolomide,Chemotherapy,Alive,WITH TUMOR,Progressive Disease,Clinical Progressive Disease,,MALE,32,C71.0,Central nervous system,Low-grade gliomas
677,B3720405-CE3F-49C7-A5D9-BBFFD06F6AEF,Temozolomide,Chemotherapy,Alive,TUMOR FREE,,,,MALE,63,C71.0,Central nervous system,Low-grade gliomas
678,B3720405-CE3F-49C7-A5D9-BBFFD06F6AEF,Procarbazine,Chemotherapy,Alive,TUMOR FREE,,,,MALE,63,C71.0,Central nervous system,Low-grade gliomas
679,9B161C41-4F76-4ED1-B60F-2B093BC70EDB,Temozolomide,Chemotherapy,Dead,WITH TUMOR,Complete Remission/Response,Clinical Progressive Disease,1242,MALE,31,C71.0,Central nervous system,Low-grade gliomas
680,61FF31A4-4FDC-476C-B456-2A2FED4BAE6B,Procarbazine,Chemotherapy,Alive,TUMOR FREE,Complete Remission/Response,Complete Response,,MALE,40,C71.0,Central nervous system,Low-grade gliomas
681,61FF31A4-4FDC-476C-B456-2A2FED4BAE6B,LOMUSTINE (CCNU),Chemotherapy,Alive,TUMOR FREE,Complete Remission/Response,Complete Response,,MALE,40,C71.0,Central nervous system,Low-grade gliomas
682,61FF31A4-4FDC-476C-B456-2A2FED4BAE6B,VINCRISTINE,Chemotherapy,Alive,TUMOR FREE,Complete Remission/Response,Complete Response,,MALE,40,C71.0,Central nervous system,Low-grade gliomas
683,A66A3847-7570-4486-8845-86B6125104A2,Temozolomide,Chemotherapy,Alive,,,Stable Disease,,FEMALE,50,C71.0,Central nervous system,Low-grade gliomas
684,CDD1FD4C-3427-496C-8391-4AEB6730D3CC,temodar,Chemotherapy,Alive,WITH TUMOR,,,,MALE,54,C71.0,Central nervous system,Low-grade gliomas
685,66C52A31-6503-40B5-A55E-FA476EAF0567,temodar,Chemotherapy,Alive,WITH TUMOR,,Stable Disease,,MALE,25,C71.0,Central nervous system,Low-grade gliomas
686,66C52A31-6503-40B5-A55E-FA476EAF0567,Vincristine,Chemotherapy,Alive,WITH TUMOR,,Stable Disease,,MALE,25,C71.0,Central nervous system,Low-grade gliomas
687,66C52A31-6503-40B5-A55E-FA476EAF0567,Procarbazine,Chemotherapy,Alive,WITH TUMOR,,,,MALE,25,C71.0,Central nervous system,Low-grade gliomas
688,66C52A31-6503-40B5-A55E-FA476EAF0567,Lomustine,Chemotherapy,Alive,WITH TUMOR,,,,MALE,25,C71.0,Central nervous system,Low-grade gliomas
689,0073A136-D5F4-4FD6-88F9-711768F2ABC6,Temodar,Chemotherapy,Alive,WITH TUMOR,,Stable Disease,,FEMALE,44,C71.0,Central nervous system,Low-grade gliomas
690,10887E42-444D-49FC-AEE5-DD0E9FC4EA54,Temodar,Chemotherapy,Alive,WITH TUMOR,Stable Disease,Stable Disease,,MALE,44,C71.0,Central nervous system,Low-grade gliomas
691,284680B2-F961-402D-8740-E5F9E4FB4A98,Temozolomide,Chemotherapy,Alive,WITH TUMOR,,,,FEMALE,36,C71.0,Central nervous system,Low-grade gliomas
692,2C982CFB-4112-4E27-8293-25AA9E01FAAE,Temodar,Chemotherapy,Alive,WITH TUMOR,Stable Disease,Partial Response,,FEMALE,35,C71.0,Central nervous system,Low-grade gliomas
693,4FB16AEE-DF08-441A-846B-558E0EFE8342,Temozolomide,Chemotherapy,Dead,WITH TUMOR,Stable Disease,,245,MALE,66,C71.0,Central nervous system,Low-grade gliomas
694,42156C6A-416E-4832-9C95-CEE6084B0910,Temodar,Chemotherapy,Alive,WITH TUMOR,Stable Disease,Stable Disease,,MALE,65,C71.0,Central nervous system,Low-grade gliomas
